Reportable - All News
reportablenews.com
All public news releases from ReportableNews.com
Articles100
DALLAS, TX -- AUGUST 12, 2026 DALLAS, TX -- August 12, 2026 -- SES AI Corp. (NYSE: SES): Stonegate Capital Partners Updates Coverage on SES AI Corp. (NYSE: SES). SES’ 2Q26 update improves the commercialization setup despite lower sequential revenue, as the quarter provided clearer evidence that the company’s broader commercial strategy is beginning to take hold. The headline miss was modest, but the underlying read-through was better: all four product lines contributed, Sol-Ark certification expands UZ Energy’s U.S. ESS opportunity, and the NDAA drone pipeline suggests capacity - not just qualification - could become a constraint as customers convert to orders. FY26 guidance was unchanged, leaving a sizable 2H ramp to execute, but the path is becoming clearer over coming quarters across ESS, drones, materials, and Molecular Universe. To view the full announcement, including downloadable images, bios, and more, click here. Key Takeaways: Commercialization is broadening across the portfolio. All four product lines generated revenue, while Sol-Ark certification materially expands UZ Energy’s U.S. ESS opportunity and supports a larger contribution beginning later in 2026 and into 2027. Drone demand is emerging as the strongest near-term growth driver. SES is scaling NDAA-compliant capacity to 1M cells annually, while ~five large prospects alone represent ~1.5M potential annual cells versus only ~700K–800K of deliverable capacity. FY26 guidance remains achievable but requires a meaningful 2H ramp. SES reaffirmed $30M–$35M of revenue and ~15% gross margin, implying $18.2M–$23.2M in 2H26, supported by ESS growth and increasing drone/materials contributions. Click image above to view full announcement. About Stonegate Stonegate Capital Partners is a leading capital markets advisory firm providing investor relations, equity research, and institutional investor outreach services for public companies. Our affiliate, Stonegate Capital Markets (member FINRA) provides a full spectrum of investment banking, equity research and capital raising for public and private companies. Contacts: Stonegate Capital Partners (214) 987-4121 info@stonegateinc.com Source: Stonegate, Inc. Distributed by: Reportable, Inc.
DALLAS, TX -- AUGUST 11, 2026 DALLAS, TX -- August 11, 2026 -- OppFi, Inc. (NYSE: OPFI): Stonegate Capital Partners Updates Coverage on OppFi (NYSE: OPFI). OppFi’s 2Q26 results weaken the near-term earnings outlook but do not change the longer-term thesis. The FY26 reset reflects delayed LOC and LOLA-related initiatives alongside macro pressure on consumer affordability, with management deliberately pacing product rollout and underwriting rather than pursuing volume at the expense of credit quality. Controlled adjusted expenses and sequentially improving charge-offs suggest the model remains intact, while OppFi prioritizes balance-sheet strength, unit economics, and risk-adjusted returns. LOC launch, LOLA migration, and improving originations should clarify a return to growth, while BNCC approval remains the larger strategic driver. To view the full announcement, including downloadable images, bios, and more, click here. Key Takeaways: Revenue increased 1.9% y/y to a second-quarter record of $145.2M, while adjusted net income declined 27.0% to $28.8M and adjusted EPS fell to $0.33 from $0.45. Although the quarter resulted in a lower FY26 outlook, adjusted operating expenses remained well controlled at approximately 34% of revenue, suggesting the earnings reset was driven primarily by origination timing and credit trends rather than deterioration in the underlying cost structure. Credit performance showed encouraging sequential improvement, with net charge-offs declining to 39.5% of revenue and 52.3% of average receivables from 42.5% and 55.5%, respectively, in 1Q26, while total net originations improved 20.5% q/q. We believe this supports management’s decision to prioritize underwriting discipline and risk-adjusted returns over near-term volume, with further credit normalization and the September LOC launch providing a potential path back toward stronger origination growth. The longer-term growth framework remains intact despite the FY26 guidance reduction, with LOC, LOLA migration, and the pending BNCC acquisition still representing the primary strategic catalysts. Management continues to target a 4Q26 BNCC close and approximately $3.00 of EPS by 2028, and we believe the acquisition could materially expand OppFi’s geographic reach, product breadth, and access to lower-cost funding as revenue synergies begin to emerge in 2027. Click image above to view full announcement. About Stonegate Stonegate Capital Partners is a leading capital markets advisory firm providing investor relations, equity research, and institutional investor outreach services for public companies. Our affiliate, Stonegate Capital Markets (member FINRA) provides a full spectrum of investment banking, equity research and capital raising for public and private companies. Contacts: Stonegate Capital Partners (214) 987-4121 info@stonegateinc.com Source: Stonegate, Inc. Distributed by: Reportable, Inc.
DALLAS, TX -- AUGUST 11, 2026 DALLAS, TX -- August 11, 2026 -- Surf Air Mobility Inc. (NYSE: SRFM): Stonegate Capital Partners Updates Coverage on Surf Air Mobility Inc. (NYSE: SRFM). SRFM’s 2Q26 results improved the forward setup, with revenue at the high end of guidance despite elevated fuel costs and Hawaii weather disruption, while the first SurfOS enterprise contract advanced commercialization. Revenue increased 8% y/y and 15% q/q to $29.5M, versus guidance of $27M-$30M, while adjusted EBITDA loss narrowed to $10.5M from $12.3M q/q, though widened from $9.5M in 2Q25. SRFM is moving beyond restructuring, with earnings supported by On Demand growth, structural airline efficiencies, initial SurfOS revenue expected in 2H26, lower financing pressure, and what we believe is a trough in scheduled service as route-exit headwinds begin to moderate. To view the full announcement, including downloadable images, bios, and more, click here. Key Takeaways: Revenue increased 8% y/y and 15% q/q to $29.5M, reaching the high end of guidance despite elevated fuel costs and weather disruption, while the adjusted EBITDA loss narrowed sequentially to $10.5M from $12.3M. We believe the quarter supports the view that SRFM is moving beyond restructuring, with route-exit headwinds beginning to moderate and structural operating efficiencies providing a stronger foundation for earnings improvement in 2H26. Surf On Demand remains the primary growth engine, with revenue increasing 101% y/y to $12.1M, departures up approximately 67%, and revenue per flight increasing 25% as mix shifted toward larger aircraft and longer flights. At the same time, SurfOS reached an important commercialization milestone with Wheels Up becoming the first Enterprise BrokerOS customer under a contract worth up to $12M, creating an initial software revenue stream and validating the broader third-party opportunity. Management reaffirmed FY26 revenue and adjusted EBITDA guidance while 3Q26 guidance implies a meaningful sequential earnings improvement, supported by On Demand growth, improving airline economics, and initial SurfOS revenue. Post-quarter financing also reduced convertible principal by 64% and monthly cash amortization by up to 50%, which we believe lowers financing pressure and gives SRFM greater flexibility to deploy working capital into charter supply and improve On Demand margins as free cash flow conversion strengthens. Click image above to view full announcement. About Stonegate Stonegate Capital Partners is a leading capital markets advisory firm providing investor relations, equity research, and institutional investor outreach services for public companies. Our affiliate, Stonegate Capital Markets (member FINRA) provides a full spectrum of investment banking, equity research and capital raising for public and private companies. Contacts: Stonegate Capital Partners (214) 987-4121 info@stonegateinc.com Source: Stonegate, Inc. Distributed by: Reportable, Inc.
DALLAS, TX -- AUGUST 11, 2026 DALLAS, TX -- August 11, 2026 -- NU Skin Enterprises Inc. (NYSE: NUS): Stonegate Capital Partners updates their coverage on NU Skin Enterprises Inc. (NYSE: NUS). NUS reported revenue, adj NI, and adj EPS of $320.1M, $10.0M, and $0.20, respectively. This compares to our estimates of $345.2M, $10.3M, and $0.20, respectively. GAAP EPS was $(5.14), primarily reflecting a $78.9M non-cash goodwill impairment, which was largely a GAAP accounting item, and a $167.5M deferred-tax valuation allowance, both excluded from adjusted results. Core Nu Skin gross margin improved 20 bps y/y to 77.7%, while consolidated gross margin declined 60 bps to 68.2% and adjusted operating margin fell 190 bps to 6.1%. Nu Skin and Rhyz revenue declined 15.5% and 25.0% y/y, respectively. Management reduced FY26 revenue guidance to $1.28B-$1.35B from $1.35B $1.50B and adjusted EPS to $0.70-$0.90 from $0.80-$1.20. India also moved to 1H27 from year-end 2026 as NUS refines local sourcing, logistics, technology integration, and the affiliate model. We believe the revised outlook reflects a lower near-term setup, with Prysm iO adoption, sales-force productivity, and cost actions remaining the primary 2027 drivers. To view the full announcement, including downloadable images, bios, and more, click here. Key Takeaways: Revenue was $320.1M in 2Q26, while adj. EPS of $0.20 matched our estimate despite a weaker top line, with Core Nu Skin gross margin improving 20 bps y/y to 77.7%. Management lowered FY26 revenue guidance to $1.28B-$1.35B and adjusted EPS guidance to $0.70-$0.90, reinforcing a softer near-term setup but leaving margin improvement and cost optimization as important levers into 2027. Prysm iO remains the central longer-term growth initiative, with more than 39,000 devices placed and 2.5M scans completed as NUS targets 50,000-60,000 devices by year-end. We increasingly view the platform as a sales-force productivity tool, with AI-enabled assessments, recommendations, and 90-day wellness plans expected to help leaders deepen customer engagement, improve conversion, and broaden monetization across beauty and wellness. Sales-force trends showed early signs of stabilization, with sales leaders down 9% y/y versus a 13% decline in 1Q and essentially flat q/q, while Mainland China sales leaders increased 2% y/y. Although recruiting remains below levels required for sustainable growth and India has shifted to 1H27, Prysm iO training, compensation changes, leadership development initiatives, and the East-West operating model provide several potential drivers for improved productivity and profitability next year. Click image above to view full announcement. About Stonegate Stonegate Capital Partners is a leading capital markets advisory firm providing investor relations, equity research, and institutional investor outreach services for public companies. Our affiliate, Stonegate Capital Markets (member FINRA) provides a full spectrum of investment banking services for public and private companies. Contacts: Stonegate Capital Partners (214) 987-4121 info@stonegateinc.com Source: Stonegate, Inc. Distributed by: Reportable, Inc.
FOR IMMEDIATE RELEASE - AUGUST 11, 2026 August 11 is National 8/11 Day and UGI Utilities is using this day to remind homeowners and contractors to always call 811, or go to call811.com to submit a request, before digging. It is a simple, and potentially lifesaving, phone call or click. To view the full announcement, including downloadable images, bios, and more, click here. Click image above to view full announcement. UGI Utilities is headquartered in Denver, Pennsylvania and serves more than 760,000 customers in certificated portions of 46 Pennsylvania counties and one county in Maryland. Customers interested in additional information should visit the UGI website at www.ugi.com; on Facebook at www.facebook.com/ugiutilities; X at https://x.com/ugi_utilities. Contacts: John Mason (610) 334-7135 jmason@ugi.com Source: UGI Utilities Distributed by: Reportable, Inc.
SAN FRANCISCO, CA - AUGUST 11, 2026 Almabase announced the launch of a unified fundraising platform purpose-built for healthcare foundations. Almabase brings together fundraising events, online giving, and fundraising marketing, helping foundations engage donors, support grateful patient programs, and build stronger fundraising pipelines, while seamlessly syncing data with Blackbaud Raiser's Edge NXT. To view the full announcement, including downloadable images, bios, and more, click here. Key Takeaways: Almabase launches a connected fundraising platform for healthcare foundations that unifies events, online giving, and donor communications while automatically syncing with Blackbaud Raiser's Edge NXT. Since implementing Almabase, Essentia Health Foundation has eliminated weeks of sponsorship follow-up, automatically synced event attendees into Raiser's Edge NXT, and raised more than $200,000 at its Essentially Yours Gala. The platform is immediately available to healthcare foundations using Blackbaud Raiser's Edge NXT, marking Almabase's expansion from higher education into healthcare. Click image above to view full announcement. About Almabase Almabase helps mission-driven organizations grow their fundraising through events, online giving, and fundraising marketing. After serving higher education institutions for more than a decade, Almabase has expanded its platform to support healthcare foundations while continuing to invest in both sectors. Contacts: Akhil Nambiar akhil@almabase.com Sushmitha Sharma sushmitha@almabase.com Source: Almabase Distributed by: Reportable, Inc.
DALLAS, TX -- AUGUST 10, 2026 DALLAS, TX -- August, 10 2026 -- Information Services Group, Inc. (NASDAQ: III): Stonegate Capital Partners Updates Coverage on Information Services Group, Inc. (NASDAQ: III). III’s 2Q26 results improved the forward setup as revenue and adj. EBITDA exceeded guidance, AI-related revenue accelerated, and recurring revenue reached a record. The differentiated read-through is that AI is strengthening both sides of ISG’s earnings model, generating demand across governance, sourcing, research, and advisory while supporting delivery efficiency, higher-value mix, and margin expansion. Underlying growth remained mid-single digits excluding FX and Martino, with growth broadening across the Americas and Europe despite measured enterprise decision-making. Record recurring revenue expands visibility beneath ISG’s project-oriented advisory work. Management said the pipeline is probably as strong as it has ever been, although client decision timing remains the primary visibility constraint. We are keeping an eye on AI governance expansion, larger opportunity conversion, recurring-revenue mix, and APAC’s return to growth. To view the full announcement, including downloadable images, bios, and more, click here. Key Takeaways: Revenue increased 6.4% y/y to $65.5M and adj. EBITDA increased 13% to $9.4M, both above guidance, while adj. EBITDA margin expanded 80 bps to 14.3%. The quarter reinforces the view that III is converting improving demand, pricing, higher-value advisory mix, and AI-enabled delivery efficiencies into better operating leverage. AI-related revenue increased 64% y/y to $26M, with nearly half of clients now generating AI-related revenue, while recurring revenue increased 7% y/y to a record $30M. We believe the combination is important to the forward setup, as AI governance is creating incremental demand across existing client relationships while recurring revenue adds greater visibility to III’s traditionally project-oriented model. Growth broadened across the Americas and Europe, while management described the pipeline as potentially the strongest it has ever been and guided to continued y/y growth and margin expansion in 3Q26. Although enterprise decision timing remains a near-term constraint, the strength of the pipeline and improving regional trends support a constructive 2H26 outlook. Click image above to view full announcement. About Stonegate Stonegate Capital Partners is a leading capital markets advisory firm providing investor relations, equity research, and institutional investor outreach services for public companies. Our affiliate, Stonegate Capital Markets (member FINRA) provides a full spectrum of investment banking, equity research and capital raising for public and private companies. Contacts: Stonegate Capital Partners (214) 987-4121 info@stonegateinc.com Source: Stonegate, Inc. Distributed by: Reportable, Inc.
DALLAS, TX -- AUGUST 10, 2026 DALLAS, TX -- August, 10 2026 -- Aemetis Inc. (NASDAQ: AMTX): Stonegate Capital Partners Updates Coverage on Aemetis Inc. (NASDAQ: AMTX). Aemetis’ 2Q26 results made the operating inflection visible, as quarterly 45Z recognition, higher RNG production, and improved ethanol economics drove positive operating income and adj. EBITDA despite India OMC tender timing. Revenue increased 20% y/y and 15% q/q to $62.7M, below $68.6M consensus, while our normalized EPS estimate of negative $0.11 exceeded negative $0.24 consensus. Underlying results were better than the revenue variance: India reflected tender timing, and both California businesses delivered higher volumes, stronger gross profit, and increased environmental-credit contribution. To view the full announcement, including downloadable images, bios, and more, click here. Key Takeaways: Revenue increased 20% y/y and 15% q/q to $62.7M, while gross profit improved to $13.5M from a $3.4M loss and adj. EBITDA reached $9.7M from negative $5.8M. The quarter made the operating inflection more visible, as quarterly 45Z recognition, higher RNG production, and improved ethanol economics more than offset weaker India revenue tied to OMC tender timing. Dairy RNG remains the clearest growth driver, with sales volume increasing 38% y/y to 146,900 MMBtu and segment gross profit rising to $4.0M from $0.9M. Seven approved LCFS pathways averaging negative 380 CI are already improving credit economics, while six additional pathways nearing approval and two digesters expected to be commissioned in 3Q26 provide additional runway for higher production, profitability, and cash flow. The Keyes earnings bridge continues to advance, with MVR targeted for operation by year-end 2026 and management estimating approximately $32M of annual value from lower natural-gas usage and incremental LCFS and 45Z benefits. While these operating improvements could materially strengthen the earnings profile beginning in 2027, the balance sheet remains the primary thesis constraint, with $1.0M of unrestricted cash, $415.9M of total debt, and refinancing progress still important to translating operating improvement into durable free cash flow. Click image above to view full announcement. About Stonegate Stonegate Capital Partners is a leading capital markets advisory firm providing investor relations, equity research, and institutional investor outreach services for public companies. Our affiliate, Stonegate Capital Markets (member FINRA) provides a full spectrum of investment banking, equity research and capital raising for public and private companies. Contacts: Stonegate Capital Partners (214) 987-4121 info@stonegateinc.com Source: Stonegate, Inc. Distributed by: Reportable, Inc.
DALLAS, TX -- AUGUST 10, 2026 DALLAS, TX -- August, 10 2026 -- Park-Ohio Holdings Corp. (NASDAQ: PKOH): Stonegate Capital Partners Updates Coverage on Park-Ohio Holdings Corp. (NASDAQ: PKOH). PKOH’s 2Q26 marked a clearer inflection in the portfolio, as wider demand and better Engineered Products execution shifted the growth mix toward higher margin, more durable businesses. Importantly, management raised FY26 guidance while retaining SSP’s expected ~$0.50/share loss, suggesting the core portfolio is improving faster than consolidated results imply. Gross margin reached its highest level since 2013, operating income increased 22% y/y, and operating cash flow improved $23M. In our view, PKOH is entering a multi-step margin and portfolio-quality improvement cycle, with Engineered Products absorption, company-specific productivity initiatives, 2H cash conversion, and the SSP review the primary variables through year-end. To view the full announcement, including downloadable images, bios, and more, click here. Key Takeaways: Revenue increased 10% y/y to $440.1M and adj. EBITDA reached $38.8M, both above our and consensus estimates, while gross margin expanded 90 bps to 17.9%, its highest level since 2013. The quarter supports the view that broader demand, higher-volume flow-through, and company-specific productivity initiatives are beginning to translate into better operating leverage across the portfolio. Engineered Products showed the clearest improvement, with revenue up 10% y/y to $129.4M and operating margin expanding 190 bps to 7.0%, while backlog increased 29% y/y to $252M. We believe the combination of stronger aftermarket activity, improved forged and machined performance, and a growing backlog is shifting PKOH’s growth mix toward higher-margin, more durable businesses and supports management’s long-term EBIT margin target above 10% for the segment. Management raised FY26 sales, adjusted EPS, and EBITDA margin guidance while retaining the expected ~$0.50/share loss from Southwest Steel Processing, suggesting the core portfolio is improving faster than consolidated results imply. With the SSP strategic review expected to conclude around year-end and unchanged FCF guidance implying stronger 2H cash conversion, portfolio simplification and cash generation remain important potential drivers of further earnings-quality improvement. Click image above to view full announcement. About Stonegate Stonegate Capital Partners is a leading capital markets advisory firm providing investor relations, equity research, and institutional investor outreach services for public companies. Our affiliate, Stonegate Capital Markets (member FINRA) provides a full spectrum of investment banking, equity research and capital raising for public and private companies. Contacts: Stonegate Capital Partners (214) 987-4121 info@stonegateinc.com Source: Stonegate, Inc. Distributed by: Reportable, Inc.
YUCCA VALLEY, CALIFORNIA- AUGUST, 6TH 2026 The Keep A Breast Foundation proudly presents the 2026 High Desert Collection, opening September 18–20, 2026, at the Likker Barn in Pioneertown, California. To view the full announcement, including downloadable images, bios, and more, click here. Key Takeaways: The Keep A Breast Foundation presents the 2026 High Desert Collection, opening September 18–20, 2026 at the Likker Barn in Pioneertown, California, with an RSVP-required opening reception Friday and public exhibition hours on Saturday and Sunday. Created by founder Shaney jo Darden and curated by participating High Desert artist Clair Case, the second edition pairs original chest casts of over 30 local community members with artists who transform them into one-of-a-kind works of art to honor the region and spark conversations around breast health and prevention. Throughout Breast Cancer Awareness Month in October, the chest casts go on display inside participating businesses along Highway 62 as a month-long public art experience coinciding with the Hwy 62 Open Studio Art Tours, and the exhibition launches Bucks for Boobies, a community-wide fundraising and awareness campaign supporting breast cancer prevention and Keep A Breast. Click image above to view full announcement. The Keep A Breast Foundation (KAB) is a 501(c)(3) nonprofit filling a critical gap in breast cancer education: reaching young people before they become patients. Founded in 2000 with a mission to reduce breast cancer risk and its impact globally through art, education, prevention and action, KAB pioneered a youth-centric approach empowering Gen Alpha, Gen Z and millennials with prevention-focused information during their teens, 20s and 30s. Through programs like the "i love boobies!" bracelet campaign and Keep A Breast app, KAB provides accessible, shame-free education about breast self-examination, risk reduction and environmental health, treating young people as partners in their health — not just future patients. Contacts: Shaney jo Darden 7608213055 shaneyjo@keep-a-breast.org Source: Keep A Breast Foundation Distributed by: Reportable, Inc.
NEW YORK, NY, AUGUST 6, 2026 The July Wellness Index Report, published by Wellness Eternal's Biohacking Index, identifies a quiet reversal in how leading practitioners approach longevity. For a century, medicine's instinct was to override biology. A new generation is working with what the body already produces and asking it to do what it was built to do. To view the full announcement, including downloadable images, bios, and more, click here. Key Takeaways: The July Wellness Index Report identifies a shift in longevity toward working with the body’s own biology rather than overriding it. The report identifies three signals: midlife hormone health moving into legitimate clinical priority, regeneration replacing repair, and a microbiome category being reshaped by published evidence. The report features International Pause Institute, PUR-FORM, and FitBiomics as companies exemplifying this shift. Click image above to view full announcement. About the Wellness Index Report The Wellness Index Report is an independent, practitioner-led research platform published monthly by Wellness Eternal. It evaluates wellness providers, technologies and protocols through a four-step process: expert nomination, customer and patient feedback, clinical review, and ongoing rating analysis. The report is distributed across major media outlets and reaches a global audience, providing visibility to solutions that meet its integrity-first standard. Practitioners, companies and innovators interested in being considered for future reports can participate by completing the official submission and review process. Contacts: Wellness Eternal — PR Team 914-846-9444 we@wellnesseternal.com Source: Newsworthy.ai Distributed by: Reportable, Inc.
OAKLAND COUNTY, MI AUGUST 5, 2026 RazMania Midwest Festival hits Metro Detroit on August 29-30, 2026, for a weekend celebrating sports, collecting and the hobby community. The two-day annual event is expected to attract thousands of attendees from across the Midwest for one of the region's premier sports & TCG collectibles festivals. To view the full announcement, including downloadable images, bios, and more, click here. Key Takeaways: RazMania Midwest Festival comes to Metro Detroit on August 29–30, 2026 at the UWM Sports Complex in Pontiac, drawing thousands for a two-day sports and TCG collectibles event. Attendees buy, sell and trade cards, comics, memorabilia and more while meeting 50+ professional athletes through autograph signings, photo ops and interactive fan experiences. RazMania partners with Pontiac United and the Boys & Girls Club of Troy to host hundreds of local youth for athlete meet-and-greets and hobby experiences. Click image above to view full announcement. About RazMania Founded by Jason Raznick, Patrick Lane, and Elliot Lane, RazMania is a sports collectibles festival that brings together professional athletes, collectors, hobby businesses and fans for a weekend dedicated to sports cards, TCG, Pokémon, comics, memorabilia and collectibles. Through athlete appearances, interactive experiences and hundreds of exhibitors, RazMania creates a destination where collectors can buy, sell, trade and celebrate the hobby together while inspiring the next generation of fans through community partnerships and youth outreach. About Pontiac United Pontiac United is a nonprofit youth and community organization dedicated to educating, empowering, mentoring, and creating opportunities for children and young adults. Pontiac United provides all youth programs completely free of charge. Programs include dance, choir, step, martial arts, basketball, baseball, robotics, tutoring, mentoring, drama and theater, college preparation, SAT and ACT support, civic engagement, leadership development, and community service opportunities. Through these programs, Pontiac United provides young people with a safe, positive, encouraging, and inclusive environment where they can discover their talents, develop confidence, build meaningful relationships, and reach their full potential. Community partnerships, sponsorships, volunteers, and donations make it possible for Pontiac United to continue offering these life-changing opportunities without placing a financial burden on the youth and families it serves. Website: www.PontiacUnited.com About Boys & Girls Club of Troy The roots of the Boys & Girls Club of Troy, as it is today known, can be traced back to 1973 when the idea of establishing a Club for local youth was formulated. Through the efforts of determined community members, the Club was incorporated in 1974, and a permanent Board of Directors was created two years later. For nearly 50 years, the Boys & Girls Club of Troy has served its community by providing a safe and positive place for young people. The mission of the Boys & Girls Club of Troy is to provide a safe, positive place for youth to Grow, Learn, Play, Interact, and Develop into Self-Reliant, Responsible, and Contributing members of the community. Website: www.bgctroy.org Media Contact Contacts: Patrick Lane (248) 466-0000 patrick@igniteit.com Source: Newsworthy.ai Distributed by: Reportable, Inc.
SALEM, NY AUGUST 4, 2026 THRIVE today announced the expansion of its consulting services to include technology leadership, artificial intelligence, cybersecurity, managed IT services, and digital transformation capabilities through a new white-label relationship with RainTech, a nationally recognized technology services provider. To view the full announcement, including downloadable images, bios, and more, click here. Key Takeaways: THRIVE has expanded its integrated consulting model to include human-centric technology, AI, cybersecurity, and managed IT services through a strategic white-label relationship with RainTech. The new services help health centers and safety-net organizations adopt technology in practical, mission-driven ways that improve operations, strengthen care delivery, and support long-term sustainability. By combining THRIVE's healthcare consulting expertise with RainTech's technology leadership, organizations gain a trusted partner that aligns technology strategy with patient outcomes, employee retention, organizational goals, governance, and community impact. Click image above to view full announcement. About THRIVE THRIVE partners with community health centers, health systems, hospitals, and other safety-net providers to strengthen leadership, strategy, finance, operations, workforce, governance, compliance, and organizational performance. Through an integrated consulting approach, THRIVE helps organizations build sustainable systems that improve care delivery, organizational resilience, and community health. About RainTech RainTech is a technology leadership and managed services company providing cybersecurity, managed IT, cloud infrastructure, compliance, AI, and strategic technology consulting to mission-driven organizations across the United States. With more than 25 years of experience, RainTech helps organizations modernize technology while maintaining a strong focus on security, governance, and operational excellence. Contacts: Bill Franz, CEO bill.franz@thriveandachieve.com Source: Knee Deep Marketing Distributed by: Reportable, Inc.
FOR IMMEDIATE RELEASE - AUGUST 3, 2026 UGI Utilities began a system upgrade project in Ashland on Monday, August 3, 2026. The natural gas main replacement is part of UGI’s commitment to provide safe and reliable service and is an opportunity for some residents and businesses to convert to natural gas. Work is expected to be completed by mid-August and impact the following streets: To view the full announcement, including downloadable images, bios, and more, click here. Click image above to view full announcement. UGI Utilities, Inc. is a natural gas and electric utility company that serves more than 760,000 customers. Additional information about UGI Utilities, Inc. is available at www.ugi.com. Contacts: John Mason (610) 334-7135 jmason@ugi.com Source: UGI Utilities Distributed by: Reportable, Inc.
QUEENS, NEW YORK - JULY 31, 2026 There’s a huge movement afoot to suggest that the future of CRM is headless, and that the days of salespeople logging into a CRM are, indeed, numbered. The vision here is that a salesperson will interact with the CRM purely through voice and maybe limited visual input using more conversational tools such as Slack or Teams, for that matter even just text messages. To view the full announcement, including downloadable images, bios, and more, click here. Key Takeaways: The author rejects the headless CRM trend, asserting that a robust visual CRM UI/UX is essential for absorbing context and making smart decisions, while voice or chat interfaces like Slack and Teams undermine strategic selling. He argues that AI increases the importance of structured CRM interfaces by sharpening the data presented to capable, human-in-the-loop sales professionals who must engage thoughtfully with the system. Wendt Partners invites readers to join the early access list for the Sell More Now with HubSpot CRM + AI Fall 2026 Roadshow showcasing its human-centered, AI-powered CRM approach. Click image above to view full announcement. About Wendt Partners: Wendt Partners is a HubSpot Elite Solutions Partner headquartered in Queens, New York City. The firm delivers enterprise CRM strategy, implementation, and optimization services for complex B2B organizations, with particular expertise in industrial, technical, and regulated industries. Serving clients ranging from high-growth startups to Fortune 500 enterprises, Wendt Partners combines deep industry knowledge with one of the most experienced HubSpot teams in the ecosystem. With offices in New York, Toronto, London, and Melbourne, the award-winning and fully accredited firm supports clients worldwide. For more information, visit www.wendtpartners.com. About HubSpot: HubSpot (NYSE: HUBS) is a leading customer platform that provides businesses with software and support to grow better. Built on a unified CRM foundation, HubSpot brings together marketing, sales, service, operations, commerce, and content management tools into a single, connected platform. Designed to help organizations attract, engage, and delight customers, HubSpot enables companies of all sizes to scale efficiently while delivering exceptional customer experiences. Headquartered in Cambridge, Massachusetts, HubSpot serves hundreds of thousands of customers worldwide through its global ecosystem of partners and developers. For more information, visit www.hubspot.com. Contacts: Doug Wendt + 1 718 841 7169 connect@wendtpartners.com Source: Wendt Partners Distributed by: Reportable, Inc.
DALLAS, TX -- JULY 31, 2026 DALLAS, TX -- July 31, 2026 -- Civeo Corporation (NYSE: CVEO): Stonegate Capital Partners Updates Coverage on Civeo Corporation (NYSE: CVEO). CVEO reported revenue and adj EBITDA of $180.0M and $23.8M, versus our estimates of $173.1M and $21.3M and consensus revenue of $172.2M. Net loss improved to $2.5M from $3.3M, operating cash flow of $11.6M versus $(2.3)M confirmed the 1Q outflow was seasonal, and capex of $3.7M remained maintenance related. The y/y decline in Adj. EBITDA from $25.0M reflects a $3.2M activist cost addback in the prior period and timing items, with unadjusted EBITDA up y/y and 1H26 Adj. EBITDA up 23% to $46.3M. To view the full announcement, including downloadable images, bios, and more, click here. Key Takeaways: The 2Q beat was higher quality than the headline y/y EBITDA decline suggests, with 1H26 Adj. EBITDA up 23% and cash conversion normalizing. North American growth is increasingly tied to the ~$1.5B LNG, infrastructure and data center pipeline, with meaningful contributions more likely beginning in 2027. The convertible issuance strengthens funding flexibility while remaining anti-dilutive below ~$53, preserving capacity for both camp deployment and selective repurchases. Click image above to view full announcement. About Stonegate Stonegate Capital Partners is a leading capital markets advisory firm providing investor relations, equity research, and institutional investor outreach services for public companies. Our affiliate, Stonegate Capital Markets (member FINRA) provides a full spectrum of investment banking, equity research and capital raising for public and private companies. Contacts: Stonegate Capital Partners (214) 987-4121 info@stonegateinc.com Source: Stonegate, Inc. Distributed by: Reportable, Inc.
FOR IMMEDIATE RELEASE - JULY 30, 2026 UGI Utilities is scheduled to begin system upgrades in Hazleton on Monday, August 3, 2026. The natural gas main replacement is part of UGI’s commitment to provide safe and reliable service and is an opportunity for some residents and businesses to convert to natural gas. Work is expected to be completed by the end of September and impact the following streets: To view the full announcement, including downloadable images, bios, and more, click here. Click image above to view full announcement. UGI Utilities, Inc. is a natural gas and electric utility company that serves more than 760,000 customers. Additional information about UGI Utilities, Inc. is available at www.ugi.com. Contacts: John Mason (610) 334-7135 jmason@ugi.com Source: UGI Utilities Distributed by: Reportable, Inc.
DALLAS, TX -- JULY 29, 2026 DALLAS, TX -- July 29, 2026 -- HyOrc Corporation (OTCQB: HYOR): Stonegate Capital Partners Initiates Coverage on HYOR. HyOrc is focused on converting refuse-derived fuel, or RDF, into green methanol. The Company’s process is designed to turn prepared municipal and industrial waste into synthesis gas, clean and condition that gas, and convert it into methanol through a catalytic synthesis process. We view the core equity story as less about broad clean-tech exposure today and more about whether HyOrc can convert its pilot and equipment-delivery history into commercial-scale methanol production. To view the full announcement, including downloadable images, bios, and more, click here. Key Takeaways: HyOrc targets green methanol production at approximately €350 per tonne versus a conventional grey methanol benchmark of about €850 per tonne, but it still must prove these economics in continuous commercial operation. The company plans to ship its fully funded initial 1 TPD Porto methanol module in September 2026 as the first step toward an 8 TPD Portugal facility, which serves as the clearest near-term commercial validation once installed and operated. Beyond methanol, HyOrc is developing external-combustion power systems for stationary generation and locomotive retrofits. The delivery of two 500 kW turbine units and the GB Railfreight memorandum of understanding provide early reference points, although both opportunities remain ahead of full commercial deployment. Click image above to view full announcement. About Stonegate Stonegate Capital Partners is a leading capital markets advisory firm providing investor relations, equity research, and institutional investor outreach services for public companies. Our affiliate, Stonegate Capital Markets (member FINRA) provides a full spectrum of investment banking, equity research and capital raising for public and private companies. Contacts: Stonegate Capital Partners (214) 987-4121 info@stonegateinc.com Source: Stonegate, Inc. Distributed by: Reportable, Inc.
FOR IMMEDIATE RELEASE - JULY 24, 2026 UGI Utilities is scheduled to begin system upgrades in Stroudsburg, Monroe County on Monday, July 27, 2026. The natural gas main replacement is part of UGI’s commitment to provide safe and reliable service and is expected to be completed by mid-August. The work will impact the following streets: To view the full announcement, including downloadable images, bios, and more, click here. Click image above to view full announcement. UGI Utilities, Inc. is a natural gas and electric utility company that serves more than 760,000 customers. Additional information about UGI Utilities, Inc. is available at www.ugi.com. Contacts: John Mason (610) 334-7135 jmason@ugi.com Source: UGI Utilities Distributed by: Reportable, Inc.
MORRISVILLE, N.C. JULY 23, 2026 iOrganBio is an innovator in intelligent cell manufacturing, redefining how human cells are engineered and produced at scale for research and therapeutic applications, including FDA-aligned New Approach Methodologies (NAMs). The company today announced the appointment of Lee L. Rubin, Ph.D., to the Company’s Scientific Advisory Board. Dr. Rubin is a leading authority in stem cell biology, regenerative medicine, and translational neuroscience, whose research has advanced the understanding of neurodegenerative diseases and contributed to the development of multiple therapeutic candidates. He is Co-Director and Principal Faculty of the Harvard Stem Cell Institute and Professor in Harvard’s Department of Stem Cell and Regenerative Biology. His pioneering work spans blood-brain barrier biology, neural stem cell differentiation, disease modeling using patient-derived induced pluripotent stem cells, and the discovery of therapeutic candidates for disorders including Parkinson’s disease, amyotrophic lateral sclerosis (ALS), and spinal muscular atrophy (SMA). To view the full announcement, including downloadable images, bios, and more, click here. Key Takeaways: iOrganBio appoints Lee L. Rubin, Ph.D., a leading authority in stem cell biology and translational neuroscience, to its Scientific Advisory Board. Dr. Rubin's extensive academic and entrepreneurial leadership will be key to expanding iOrganBio’s platform in neurological applications. iOrganBio’s CellForge platform combines AI prediction, biological sensing, and automated 3D incubation to engineer human cells and organoids with greater precision and consistency, enabling scalable production for disease modeling, drug discovery, and cell therapy development. Click image above to view full announcement. About iOrganBio iOrganBio is transforming human cell production with CellForge™, its AI-powered platform for consistent, scalable, and intelligent manufacturing of cells and organoids for in vitro modeling and cell therapies. By applying engineering precision to biology, CellForge uses AI and automation to guide cell development and make real-time adjustments aligned with defined biological profiles. At the core of the platform is iOrganBio’s functional human CellAtlas™, a comprehensive reference built from single-cell and multi-omics data that provides the digital blueprints for each cell type. This smart, closed-loop process delivers the accuracy, efficiency, and quality partners need to turn scientific ideas into breakthroughs, accelerating disease modeling, regenerative medicine, and drug development. For more information, visit iOrgan.Bio or follow us on LinkedIn Contacts: Michelle Linn michelle@linndencom.com Source: iOrganBio Distributed by: Reportable, Inc.
BOSTON, JULY 21, 2026 Reportable today launched version 2.0 of the Reportable News Release, adding structured content and backend optimization designed to help company announcements be understood and surfaced by AI platforms and traditional search engines. To view the full announcement, including downloadable images, bios, and more, click here. Key Takeaways: Reportable version 2.0 is structured to help AI platforms and search engines understand and surface company announcements. The release retains a reporter-focused design with summaries, key takeaways, quotes, images, videos and downloadable resources. Reportable’s new Splash template provides a more visual presentation while preserving one authoritative destination for the complete announcement. Click image above to view full announcement. About Reportable Reportable is a communications platform that helps organizations publish, distribute and measure company news while tracking the brand, industry and competitor developments that matter. The Reportable News Release combines concise summaries, key takeaways, featured quotes, images, videos, executive profiles, downloadable resources, FAQs and calls to action in an interactive, media-rich format. Its structured content and backend data are designed to support discovery by search engines and generative AI platforms while giving reporters, investors, customers, partners and other audiences the information and assets they need to understand and act on the news. Reportable’s Lede & Link distribution model syndicates the essential elements of an announcement across news sites, search channels and reporter inboxes while directing audiences to the complete interactive release on a branded, authoritative destination. Reportable also provides media intelligence that filters millions of online sources to deliver succinct daily or near-real-time alerts covering a company, its industry and its competitors. Reportable is based in the Boston area. Learn more at reportablenews.com. Contacts: Savannah Beaver savannah@reportablenews.com Source: Reportable Distributed by: Reportable, Inc.
DALLAS, TX -- JULY 20, 2026 DALLAS, TX -- July 20, 2026 -- Xperi Inc. (NYSE: XPER): Stonegate Capital Partners Initiates Coverage on Xperi Inc. (NYSE: XPER). Xperi’s 1Q26 results increased confidence that its earnings inflection is underway. Topline benefited from earlier contract signings in Consumer Electronics and Connected Car, but the more meaningful change was the cost base as adjusted operating expense fell 14%, lifting adjusted EBITDA margin to 22.1% from 14.4%. Management said first-quarter expenses are a fair run rate, giving the Company room to translate Media Platform growth into earnings without relying on further large cost actions. TiVo One’s expanding audience is beginning to support advertising revenue, reinforcing the shift toward post-deployment monetization. We are keeping our eye on TiVo One ARPU, the second-half advertising ramp, and the first AutoStage data licenses as markers of continued progress. To view the full announcement, including downloadable images, bios, and more, click here. Key Takeaways: The cost reset materially improves earnings visibility: A 14% reduction in adjusted operating expense establishes a lower run-rate cost base and supports sustained operating leverage toward the 17%–19% EBITDA margin target. Media Platform is emerging as the core growth and mix driver: TiVo One audience growth, expanding advertising demand, and broader programmatic capabilities support a higher-quality, recurring monetization model. Execution milestones should drive the next leg of the story: TiVo One ARPU expansion, the second-half advertising ramp, and initial AutoStage data licensing are the key catalysts for earnings upside and multiple expansion. Click image above to view full announcement. About Stonegate Stonegate Capital Partners is a leading capital markets advisory firm providing investor relations, equity research, and institutional investor outreach services for public companies. Our affiliate, Stonegate Capital Markets (member FINRA) provides a full spectrum of investment banking, equity research and capital raising for public and private companies. Contacts: Stonegate Capital Partners (214) 987-4121 info@stonegateinc.com Source: Stonegate, Inc. Distributed by: Reportable, Inc.
FOR IMMEDIATE RELEASE - JULY 20, 2026 UGI Utilities is scheduled to begin system upgrades in Lyons Borough, Berks County on Monday, July 20, 2026. The work is part of UGI’s commitment to provide safe and reliable service and is an opportunity for some homes and businesses along the project route to convert to natural gas. To view the full announcement, including downloadable images, bios, and more, click here. Click image above to view full announcement. UGI Utilities, Inc. is a natural gas and electric utility company that serves more than 760,000 customers. Additional information about UGI Utilities, Inc. is available at www.ugi.com. Contacts: John Mason (610) 334-7135 jmason@ugi.com Source: UGI Utilities Distributed by: Reportable, Inc.
FOR IMMEDIATE RELEASE - JULY 17, 2026 UGI Utilities is scheduled to begin system upgrades in Oxford Borough, Chester County on Tuesday, July 21, 2026. The work is part of UGI’s commitment to provide safe and reliable service and is an opportunity for some homes and businesses along the project route to convert to natural gas. To view the full announcement, including downloadable images, bios, and more, click here. Click image above to view full announcement. UGI Utilities, Inc. is a natural gas and electric utility company that serves more than 760,000 customers. Additional information about UGI Utilities, Inc. is available at www.ugi.com. Contacts: John Mason (610) 334-7135 jmason@ugi.com Source: UGI Utilities Distributed by: Reportable, Inc.
FOR IMMEDIATE RELEASE - JULY 17, 2026 UGI Utilities is scheduled to begin system upgrades in Jersey Shore Borough, Lycoming County on Monday, July 20, 2026. The work is part of UGI’s commitment to provide safe and reliable service and is an opportunity for some homes and businesses along the project route to convert to natural gas. To view the full announcement, including downloadable images, bios, and more, click here. Click image above to view full announcement. UGI Utilities, Inc. is a natural gas and electric utility company that serves more than 760,000 customers. Additional information about UGI Utilities, Inc. is available at www.ugi.com. Contacts: John Mason (610) 334-7135 jmason@ugi.com Source: UGI Utilities Distributed by: Reportable, Inc.
BELLEVUE, WA & AUSTIN, TX JULY 16, 2026 Fusion leaders Type One Energy and ExoFusion further their partnership on stellarator optimization with a focus on maximizing confinement. The ongoing work will reduce time to Commercially Viable Fusion (CVF) by optimizing the edge region of the plasma. ExoFusion’s expertise and IP, combined with Type One Energy’s leadership in stellarator engineering and science is a strong accelerant to CVF. To view the full announcement, including downloadable images, bios, and more, click here. Key Takeaways: ExoFusion and Type One Energy continue strong partnership Confinement is key to Stellarator Optimization Physics partnerships are crucial to CVF Click image above to view full announcement. About ExoFusion ExoFusion is an innovative company focused on accelerating the path to Commercially Viable Fusion (CVF). ExoFusion is a leader in the physics and technologies of confinement of novel materials for the first wall. ExoFusion focuses on design, simulation, IP, and scientific innovation for growing Fusion industry. ExoFusion is a recipient of ARPA-E, SCIDAC, FIRE, INFUSE and other grants. The company works across device types and fuel cycles. About Type One Energy Type One Energy Group is mission-driven to provide sustainable, affordable fusion power to the world. Established in 2019 and venture-backed in 2023, the company is led by a team of globally recognized fusion scientists with a strong track record of building state-of-the-art stellarator fusion machines, together with veteran business leaders experienced in scaling companies and commercializing energy technologies. Type One Energy applies proven advanced manufacturing methods, modern computational physics and high-field superconducting magnets to develop its optimized stellarator fusion energy system. Its FusionDirect™ development program pursues the lowest-risk, shortest-schedule path to a fusion power plant over the coming decade, using a partner-intensive and capital-efficient strategy. Type One Energy is committed to community engagement in the development and deployment of its clean energy technology. Contacts: Romi Mahajan, CEO ExoFusion romi@thekkmgroup.com Source: ExoFusion Distributed by: Reportable, Inc.
NORWELL, MA – JULY 15, 2026 Jett Foundation announced its most ambitious milestone to date: the launch of a capital campaign to fund the building of Jett’s Place, a premier wellness and retreat center serving as a dedicated sanctuary for individuals and families affected by Duchenne muscular dystrophy (DMD). The fundraising campaign was anchored in its initial phase by two transformative $1 million donations from the Emilson Family and ITF Therapeutics. To view the full announcement, including downloadable images, bios, and more, click here. Key Takeaways: Jett Foundation launches a capital campaign to build Jett’s Place, a dedicated wellness and retreat center for individuals and families affected by Duchenne muscular dystrophy, with initial $1 million gifts from the Emilson Family and ITF Therapeutics. Located on a 10-acre campus in Norwell, Massachusetts, Jett’s Place will serve as Jett Foundation’s national headquarters and provide barrier-free accessibility, specialized wellness care, adaptive nature and recreation, and educational programs designed with input from Duchenne families. The campaign sets a $10.7 million goal and has already raised over $5 million during its quiet phase, as Jett Foundation invites broader community support to bring the project to life. Click image above to view full announcement. About Duchenne Muscular Dystrophy Diagnosed during childhood, Duchenne is a progressive neuromuscular disorder that causes a loss of motor, pulmonary, and cardiac function, and premature death. It affects every 1 in 5,000 live male births and some females. Duchenne has no cure. Children with Duchenne are born seemingly healthy and decline over time, usually losing their ability to walk around the age of 12 and succumbing to the disease in their early to mid-twenties. About Jett Foundation Since 2001, Jett Foundation, headquartered in Norwell, Mass., has worked to empower people and families impacted by Duchenne muscular dystrophy through the development of transformative programming, educational opportunities, and ongoing support for every stage of a Duchenne journey. Jett Foundation is a registered charity with 501(c)(3) status from the IRS; all donations are tax-deductible. www.jettfoundation.org. About ITF Therapeutics ITF Therapeutics was established in January 2024 as the United States affiliate of Italfarmaco Group to develop and commercialize treatments for rare diseases. The company combines end-to-end commercial execution with close listening to learn directly from advocates, researchers, clinicians, and families, ensuring their perspectives help shape the design of innovative and potentially life-changing solutions. With deep expertise across regulatory, commercial operations, access, and community partnerships, ITF Therapeutics is focused on delivering proven therapies with urgency, ambition, and compassion to each rare disease community it serves. For more information visit www.itftherapeutics.com. Contacts: Gabriella Costa, Marketing & Communications, Jett Foundation garbriella@jettfoundation.org Source: Jett Foundation Distributed by: Reportable, Inc.
SALINAS, CALIF., JULY 9, 2026 Reservoir today announced its pilot expansion into Arizona with a new location live and operational on October 1, 2026, in time for the fall and winter growing season. Developed in collaboration with the University of Arizona’s Yuma Center for Excellence in Desert Agriculture (YCEDA) and the Yuma Agricultural Center (YAC), Reservoir will extend the company’s on-farm innovation model into one of the nation’s most important specialty crop regions. To view the full announcement, including downloadable images, bios, and more, click here. Key Takeaways: Reservoir will extend the company’s on-farm innovation model into Arizona - one of the nation’s most important specialty crop regions. By placing the Yuma Agricultural Center at the center of the Arizona effort, Reservoir is strengthening the connection between field research, commercial production and startup development. This expansion builds on a longstanding relationship between the agricultural industries of Salinas and Yuma. Often called Salinas's "sister city," Yuma grows an estimated 90% of the nation's leafy greens during the winter season, from November through March. Click image above to view full announcement. ABOUT RESERVOIR Reservoir is a new rural institution that combines an agricultural innovation platform with a venture capital fund to advance the impact of rugged AI in critical industries, especially agriculture. Reservoir Farms are the world’s first on-farm robotics innovation centers, starting in the Salinas Valley and expanding to other key regions across California and the American West. Reservoir VC backs startups solving real problems in specialty crops that compound to other outdoor industries and across the rugged physical AI stack. By combining R&D space, hands-on grower input, and early-stage capital, Reservoir helps turn promising ideas into tools for the growers who feed the world. Learn more at https://reservoir.co. Contacts: Jennifer Goldston jennifer@agtechpr.com Source: Reservoir Distributed by: Reportable, Inc.
DALLAS, TX -- JULY 9, 2026 DALLAS, TX -- July 9, 2026 -- Aebi Schmidt Holding AG (NASDAQ: AEBI): Stonegate Capital Partners Initiates Coverage on Aebi Schmidt Holding AG (NASDAQ: AEBI). AEBI’s 1Q26 sales line was muted, but not because demand softened. Reported sales were $456M, roughly flat on the Company’s combined basis, while like-for-like sales increased 7% excluding Blue Arc. The quarter followed AEBI’s normal seasonal cadence, with order intake up 9% to $508M and backlog reaching $1.26B, up 23% y/y. Management expects backlog conversion to become more visible in 2Q26 and through the second half, especially in North America walk-in vans. Adjusted EBITDA increased 6% to $33.1M, with margin up 40 bps to 7.3%, driven by Europe margin improvement while North America absorbed ramp costs ahead of expected conversion. To view the full announcement, including downloadable images, bios, and more, click here. Key Takeaways: 1Q26 softness reflects revenue timing, not demand erosion, with comparable sales up 7%, orders up 9%, and backlog at $1.26B. North America remains the primary post-Shyft value driver, supported by walk-in van conversion, throughput gains, and aftermarket mix expansion. Execution is centered on converting backlog into EBITDA, working capital release, and leverage reduction toward management’s ≤2.0x year-end target. Click image above to view full announcement. About Stonegate Stonegate Capital Partners is a leading capital markets advisory firm providing investor relations, equity research, and institutional investor outreach services for public companies. Our affiliate, Stonegate Capital Markets (member FINRA) provides a full spectrum of investment banking, equity research and capital raising for public and private companies. Contacts: Stonegate Capital Partners (214) 987-4121 info@stonegateinc.com Source: Stonegate, Inc. Distributed by: Reportable, Inc.
FRANKENMUTH, MICHIGAN AND ST. LOUIS – JULY 8, 2026 Star of the West Milling Company launched its 2026 Sustainable Tracking of Agronomic Resources (STAR) program, incorporating Ostara’s CG P2X™ fertilizer to help farmers deliver measurable sustainability outcomes while meeting growing demand from food companies for supply chain transparency. The STAR program focuses on the Great Lakes Grain Initiative and is supported through the USDA Natural Resources Conservation Service’s Advancing Markets for Producers (AMP) grant. To view the full announcement, including downloadable images, bios, and more, click here. Key Takeaways: Star of the West Milling Company launched its 2026 Sustainable Tracking of Agronomic Resources (STAR) program, incorporating Ostara’s CG P2X™ fertilizer to help farmers deliver measurable sustainability outcomes The program enables Star of the West to provide downstream food companies with credible data on supply chain impacts, helping meet increasing sustainability reporting requirements. The program is designed to create value for farmers who adopt or expand sustainability practices when supplying wheat, dry beans or food grade soybeans. Click image above to view full announcement. About Star of the West Star of the West Milling Co. is a 156-year-old company with headquarters in Frankenmuth, Michigan. Star of the West is a leader in the agricultural industry, and serves customers in many areas including agronomy, beans (soy, edible, dry & organic), corn, wheat and flour. It began with one flour mill, one location and one state and now operates 32 locations in six states including four flour mills in Indiana, Michigan, New York and Ohio. The company has expanded from its flour roots to include five agronomy locations and eighteen elevators, along with dry bean and food grade soybean processing. Their organic division, Everbest Organics, operates in Michigan, Minnesota and North Dakota. About Ostara | CG P2X Ostara is a leading producer of phosphate fertilizers designed to deliver nutrients when and where crops need them most. Its flagship product, CG P2X™, the next evolution of Crystal Green®, is the first and only highly efficient phosphate fertilizer proven to release nutrients in response to crop demand. Ostara CG Pearl® is a phosphate fertilizer made through advanced nutrient recovery. Ostara fertilizer products play a key role in the agriculture sector through a network of established retailers and distributors in North America and Europe. Learn more about Ostara at Ostara.com, and explore CG P2X at PhosphatePerfected.com. Contacts: Lisa Woodkey Lisa.Woodke@starofthewest.com Erika Hanna Erika@SoldierCreekCommunications.com Source: Ostara Distributed by: Reportable, Inc.
NEW YORK, NY JULY 2, 2026 The latest Wellness Index Report, published by Wellness Eternal's Biohacking Index, points to a meaningful turn in what people want from their health. After years of chasing lifespan and longevity metrics, consumers are increasingly asking a different question: not "how do I live longer," but "why do I feel the way I do, and how do I improve my quality of life today." To view the full announcement, including downloadable images, bios, and more, click here. Key Takeaways: The Wellness Index Report finds consumers pivot from chasing lifespan metrics to prioritizing how they feel today and improving quality of life. It identifies three defining trends: personalized, data-driven diagnostics moving into everyday wellness to uncover root causes; surging demand for non-pharmaceutical pain management, with at-home and practitioner-guided recovery among the fastest-moving categories; and a renewed emphasis on human connection, purpose, and mental wellness. Taken together, the findings outline an integrated, whole-person wellness model that blends personalized diagnostics, preventive strategies, emotional resilience, non-pharmaceutical pain management, and community connection. Click image above to view full announcement. About the Wellness Index Report The Wellness Index Report is a practitioner-led evaluation platform that assesses wellness providers and technologies through a four-step process: expert nomination, customer feedback, clinical and scientific review, and ongoing rating analysis. Verified expert feedback is gathered through a proprietary survey delivered monthly to more than 100,000 doctors, clinic and wellness-center owners, and biohackers, through partnerships with medical-education leader Boston BioLife and the long-running naturopathic research journal NDNR.com. The Report is an independent research platform designed to provide transparent, third-party validation in the rapidly growing wellness and biohacking industry. About Wellness Eternal Wellness Eternal is the parent company of the Biohacking Index, the "Yelp of the health, wellness, longevity, and biohacking industry." Each company in the index is hand-selected by a member expert or physician, screened through a rigorous review process, and given the opportunity to climb the rankings through a verified, SEO- and AEO-optimized and news media promoted profile. Contacts: Wellness Eternal PR Team 914-846-9444 we@wellnesseternal.com Source: Newsworthy.ai Distributed by: Reportable, Inc.
FOR IMMEDIATE RELEASE - JULY 1, 2026 UGI Utilities is scheduled to begin system upgrades in Mount Carmel on Monday, July 6, 2026. The work is part of UGI’s commitment to provide safe and reliable service and is an opportunity for some homes and businesses along the project route to convert to natural gas. To view the full announcement, including downloadable images, bios, and more, click here. Click image above to view full announcement. UGI Utilities, Inc. is a natural gas and electric utility company that serves more than 760,000 customers. Additional information about UGI Utilities, Inc. is available at www.ugi.com. Contacts: John Mason (610) 334-7135 jmason@ugi.com Source: UGI Utilities Distributed by: Reportable, Inc.
WEST PALM BEACH, FLORIDA JUNE 30, 2026 Lifespan Edge, the next-generation longevity clinic co-founded by futurist John Mauldin and preventive medicine pioneer Dr. Michael Roizen, today announced the opening of two new locations in West Palm Beach, Florida, and Columbia, Maryland, with a third premier destination planned for Scottsdale, Arizona. To view the full announcement, including downloadable images, bios, and more, click here. Key Takeaways: Lifespan Edge opens two new locations in West Palm Beach, Florida, and Columbia, Maryland, with a premier destination planned for Scottsdale, Arizona. Each clinic delivers a concierge-style, physician-led model that combines advanced diagnostics with personalized prevention strategies to support performance, healthy aging, and long-term wellness. The company highlights research into Therapeutic Plasma Exchange, citing AMBAR trial findings that show promise in slowing aspects of cognitive and functional decline in Alzheimer’s patients while emphasizing the need for further study. Click image above to view full announcement. Lifespan Edge Our mission is to empower individuals to live longer, healthier, and more fulfilling lives through a personalized, data-driven approach to wellness. Committed to research and innovation, we are building the world’s most comprehensive TPE database, pioneering new advancements in longevity science. Guided by our dedication to making a genuine impact, we strive to be a trusted partner in every person’s journey toward optimal health and vitality. Contacts: Justin Yeo 469-430-1555 info@lifespan-edge.com Source: Newsworthy.ai Distributed by: Reportable, Inc.
BOCA RATON, FLORIDA JUNE 30, 2026 As Americans prepare to celebrate Independence Day, veteran entrepreneur and distribution executive Mitch Gould is reflecting on the entrepreneurial spirit that has defined both his own career and the opportunities available to innovators who pursue the American Dream. To view the full announcement, including downloadable images, bios, and more, click here. Key Takeaways: Mitch Gould marks Independence Day by highlighting the enduring American Dream and the value of hard work, risk-taking, and persistence for entrepreneurs. His memoir, The Blonde, The Ferrari & The Kwan, shares lessons, relationships, and defining moments from more than three decades in the consumer products industry. Through Nutritional Products International's Evolution of Distribution®, Gould helps international companies enter the U.S. market by unifying logistics, regulatory guidance, retail placement, e-commerce strategy, and post-placement marketing. Click image above to view full announcement. About Nutritional Products International (NPI) Nutritional Products International (NPI) is a U.S.-based retail consulting and distribution firm founded by retail distribution expert Mitch Gould. With more than three decades of experience, Gould has helped domestic and international brands successfully enter and expand within the U.S. market, representing high-profile brands and celebrities including Steven Seagal, Hulk Hogan, Ronnie Coleman, and Wayne Gretzky. NPI works closely with manufacturers and major retailers to guide products from concept to shelf, providing strategic support across retail introductions, regulatory readiness, operations planning, and market visibility through its proprietary Evolution of Distribution® platform. The company is known for helping brands navigate the complexities of U.S. retail efficiently while building long-term, scalable growth. About Mitch Gould Mitch Gould is a third-generation retail distribution and manufacturing expert with more than 25 years of experience launching and scaling consumer products across dietary supplements, sports nutrition, skincare, hardware, and beverages. He has worked with iconic consumer brands such as Igloo, Rubbermaid, Sunbeam, and Miracle-Gro, as well as high-profile celebrity brands including Steven Seagal, Hulk Hogan, Chuck Liddell, 8× Mr. Olympia Ronnie Coleman, and martial arts pioneer Bob Wall. Over the course of his career, Gould has played a key role in helping shape the growth of the U.S. sports nutrition category-supporting the expansion of performance-focused products across major retail and e-commerce platforms, including Amazon, Walmart, GNC, CVS, and Walgreens. His work has centered on bringing muscle-building, recovery, and performance-oriented products to a broader consumer audience. Gould is known for his hands-on, execution-driven approach to building consumer brands at scale and for his deep understanding of what drives success in highly competitive categories such as sports nutrition and dietary supplements. He continues to focus on the evolving intersection of performance, wellness, and consumer demand for effective, results-driven products. Contacts: M. Willaman 561-544-0719 mwillaman@indistributionmedia.com Source: Nutritional Products International Distributed by: Reportable, Inc.
FOR IMMEDIATE RELEASE - JUNE 29, 2026 UGI Utilities is working during nighttime hours in Manheim, Lancaster County through Thursday, July 2, impacting traffic at Market Square. The natural gas main replacement project is part of UGI’s commitment to provide safe and reliable service. To view the full announcement, including downloadable images, bios, and more, click here. Click image above to view full announcement. UGI Utilities, Inc. is a natural gas and electric utility company that serves more than 760,000 customers. Additional information about UGI Utilities, Inc. is available at www.ugi.com. Contacts: John Mason (610) 334-7135 jmason@ugi.com Source: UGI Utilities Distributed by: Reportable, Inc.
DALLAS, TX -- JUNE 26, 2026 DALLAS, TX -- June 26th, 2026 --Burcon Nutrascience Corporation (TSX: BU): Stonegate Capital Partners updates their coverage on Burcon Nutrascience Corporation (TSX: BU). Burcon has moved from commissioning and into early utilization, with growing customer volume setting up better fixed-cost absorption at Galesburg. The Company completed commissioning and launched commercial production across Peazazz pea protein, Puratein C canola protein, and FavaPro fava protein in FY26. Revenue increased sequentially to $0.83M in 4Q26 from $0.74M in 3Q26, and management indicated current-quarter sales were tracking toward ~50% sequential growth based on April/May activity. Burcon also set a new production record, with daily output roughly 60% above January - March levels. As volume builds, the margin opportunity should come from better utilization, steadier production cadence, and start-up costs moving out of the run-rate cost structure, rather than pricing alone. To view the full announcement, including downloadable images, bios, and more, click here. Key Takeaways: Burcon is moving into utilization ramp mode, with 4Q26 revenue of $0.83M and current-quarter sales tracking ~50% higher sequentially. Customer traction is broadening, with 30+ purchasing customers and 200+ active projects across pea, canola, and fava applications. Funding supports the Galesburg scale-up, with $6.9M completed, $3.0M undrawn, and management targeting $10M of CY26 sales. Click image above to view full announcement. About Stonegate Stonegate Capital Partners is a leading capital markets advisory firm providing investor relations, equity research, and institutional investor outreach services for public companies. Our affiliate, Stonegate Capital Markets (member FINRA) provides a full spectrum of investment banking services for public and private companies. Contacts: Stonegate Capital Partners (214) 987-4121 info@stonegateinc.com Source: Stonegate, Inc. Distributed by: Reportable, Inc.
CAMBRIDGE, MASS - JUNE 25, 2026 - Ketryx, the agentic continuous compliance platform for safety-critical product development, announced today that William A. Hawkins, former Chairman and CEO of Medtronic, has joined its Board of Directors. To view the full announcement, including downloadable images, bios, and more, click here. Key Takeaways: Ketryx announces that William A. Hawkins, former Chairman and CEO of Medtronic, joins its Board of Directors and also participated in the company’s Series B financing. Ketryx helps companies in safety-critical industries, including medical devices, pharmaceuticals, and robotics, accelerate product development by automatically generating compliant documentation, maintaining continuous traceability, and enabling safe and verifiable AI at scale in the tools teams already use. Click image above to view full announcement. About Ketryx Ketryx transforms the product lifecycle of life sciences teams to deliver safer products, faster. Trusted by four of the world's top five medical device manufacturers, its agentic continuous compliance platform overlays existing tools to automate documentation, create traceability, and accelerate release cycles without disrupting existing workflows. Ketryx AI Agents reduce manual work by up to 90 percent and help teams identify and close compliance gaps, improving both speed and quality across the product lifecycle. For more information, visit www.ketryx.com. Contacts: Brian Kramer press@ketryx.com Source: Ketryx Distributed by: Reportable, Inc.
CALGARY, ALBERTA — JUNE 23, 2026 — Anchorbase, a payments and automation platform for mid-market businesses, today announced it has raised a $2 million USD pre-seed round backed by Cambrian VC and TTV Capital. To view the full announcement, including downloadable images, bios, and more, click here. Key Takeaways: Anchorbase, a payments and automation platform for mid-market businesses, has raised a $2 million USD pre-seed round backed by Cambrian VC and TTV Capital. Anchorbase uses AI to automate payment collection, reconciliation, reporting, and back-office workflows within the software that companies already use. Businesses can initiate payments inside their existing DMS, CRM, accounting system, or operational software, collect funds through a terminal or payment link, automatically reconcile payments to the correct invoice, and trigger the next workflow – all without switching between disconnected tools. The company's new funding will support continued product development, deeper integrations with systems of record, expanded customer support, and go-to-market growth across North America. Click image above to view full announcement. About Anchorbase Anchorbase is a payments and automation platform for mid-market businesses. The company connects payments, systems of record, and back-office workflows to help businesses automate reconciliation, reporting, exception handling, and operational tasks without requiring a major system migration. Anchorbase is headquartered in Calgary, Alberta. Contacts: media@anchorbase.com Source: Anchorbase Distributed by: Reportable, Inc.
SAN FRANCISCO, CA - JUNE 23, 2026 - Momentic, the quality platform for engineers and agents, today launched a major platform update that rethinks software verification for the AI era. AI coding tools have made it possible for teams of all sizes to ship more code than ever before, but how that code gets validated has not kept up. The result is bugs reaching production faster than teams can catch them, and engineering teams stuck firefighting hotfixes instead of shipping. To view the full announcement, including downloadable images, bios, and more, click here. Key Takeaways: Momentic launches a major platform update that rethinks software verification for the AI era by delivering an agentic quality platform that scales coverage as AI accelerates code to production. The platform’s agents run on a shared product knowledge base and include an Explore Agent that automatically expands test coverage, a Failure Classification Agent that categorizes failures and opens PRs to heal non-bugs, and an intent-based test format readable by humans and AI. Early beta results show the agents analyze over 70,000 test failures, open 400 pull requests, write 600 tests with a 73% merge rate, execute more than 2 billion steps, and verify over 80,000 PRs. Click image above to view full announcement. About Momentic Momentic, Inc. is the agentic quality platform for engineers and agents. Companies like Notion, Xero, Bilt, Webflow, and SPS Commerce use Momentic to prevent incidents from reaching customers as the volume of code produced scales exponentially with AI. Momentic helps organizations ship fewer bugs to production and eliminate the engineering time lost to test maintenance. The solution provides comprehensive cross-platform support for web, Android, and iOS applications. Momentic was founded in late 2023 and is backed by Standard Capital, Y Combinator, FCVC, Transpose Platform, Dropbox Ventures, and Karman Ventures. The company is headquartered in San Francisco, California. For more information, visit momentic.ai. Contacts: press@momentic.ai Source: Momentic Distributed by: Reportable, Inc.
FOR IMMEDIATE RELEASE - JUNE 22, 2026 UGI Utilities is set to begin system upgrades in Clearfield on Tuesday, June 23, 2026. The work is part of UGI’s commitment to provide safe and reliable service. The work on four sections of natural gas mains is expected to be completed by the end of July and impact the following streets: To view the full announcement, including downloadable images, bios, and more, click here. Click image above to view full announcement. UGI Utilities, Inc. is a natural gas and electric utility company that serves more than 760,000 customers. Additional information about UGI Utilities, Inc. is available at www.ugi.com. Contacts: John Mason (610) 334-7135 jmason@ugi.com Source: UGI Utilities Distributed by: Reportable, Inc.
SALINAS, CALIF. — JUNE 22, 2026 Reservoir announced that Nicola Kerslake has joined the firm as general partner following Reservoir’s acquisition of the agriculture finance and data platform: Contain, Inc. Kerslake will chair Reservoir VC's investment committee and lead its due diligence and underwriting functions. Terms of the deal were not disclosed. To view the full announcement, including downloadable images, bios, and more, click here. Key Takeaways: Reservoir announced that Nicola Kerslake has joined the firm as general partner following Reservoir’s acquisition of the agriculture finance and data platform: Contain, Inc. The transaction marks Reservoir’s first acquisition and adds a new layer to its value creation model for startups. By adding Contain’s marketplace, underwriting, financing experience and market intelligence capabilities, Reservoir is expanding how it can help startups move from pilot to commercial scale. Click image above to view full announcement. ABOUT RESERVOIR: Reservoir is an agricultural innovation center and venture capital fund focused on helping agtech startups succeed where agriculture happens—in the field. Reservoir Farms are the world’s first on-farm robotics innovation centers, starting in the Salinas Valley and expanding to other key regions across California and the American West. Reservoir VC backs startups solving real problems in high-value crops and the rugged physical AI stack. By combining R&D space, hands-on grower input, and early-stage capital, Reservoir helps turn promising ideas into tools for the growers who feed the world. Learn more at https://reservoir.co. Contacts: Jennifer Goldston jennifer@AgtechPR.com Source: Reservoir Distributed by: Reportable, Inc.
SALT LAKE CITY, UTAH – JUNE 18, 2026 BioUtah, Utah’s life sciences trade association, is proud to announce that President and CEO Kelvyn Cullimore, along with key partners — the Governor’s Office of Economic Development, Nucleus Institute, University of Utah Technology Licensing Office, World Trade Center Utah, Utah Inland Port Authority, The Point Utah, Salt Lake City Department of Economic Development, Economic Development Corporation of Utah, — will co-host the Utah Pavilion at the BIO International Convention, held June 22–25 in San Diego, CA. To view the full announcement, including downloadable images, bios, and more, click here. Key Takeaways: Discover Utah’s Thriving Life Sciences Industry: The Utah Pavilion will showcase the state’s rapidly expanding life sciences sector, recognized as one of the fastest-growing in the nation — a prime opportunity to learn about a dynamic and successful bio ecosystem. Connect with Key Players and Explore Collaboration: The Pavilion is a central meeting point to engage with the leaders, innovators, decision-makers, researchers, and entrepreneurs shaping Utah’s life sciences future, fostering an environment for potential partnerships and investment. Experience a Collaborative, Business-Friendly Environment: Utah’s life sciences community is defined by its unique culture of collaboration among industry, government, and universities, anchored by a highly educated workforce and a pro-business environment essential to a robust bioscience hub. Click image above to view full announcement. About BioUtah BioUtah is an independent 501(c)(6) trade association serving Utah’s life sciences industry. Its member companies reflect a broad spectrum with strengths in medical device manufacturing and services, research and testing, biotechnology, biopharmaceuticals, and diagnostics, among others, and are a key driver of Utah’s economy and the advancement of healthcare. Contacts: Denise Bell denise@bioutah.org Source: BioUtah Distributed by: Reportable, Inc.
CITY OF CARSON, CA - JUNE 17, 2026 The City of Carson will officially launch its community-wide countdown to the 2028 Olympic and Paralympic Games on Wednesday, June 24, with the official Carson Experience launch event and unveiling of a 700-pound Olympic countdown clock at 9:25 a.m. at Carson Park, 21411 Orrick Ave. To view the full announcement, including downloadable images, bios, and more, click here. Key Takeaways: Carson officially begins its road to LA28. The City will launch the Carson Experience and unveil a nearly 700-pound Olympic countdown clock, marking the official start of its community-wide countdown to the 2028 Olympic and Paralympic Games. Youth and Olympians will lead the celebration. Hundreds of Carson youth will join Olympic Gold Medalist Steve Lewis, Team USA Rugby Sevens player Marcus Tupuola, City leaders and LA28 representatives in a celebration highlighting Carson's Olympic legacy and future. The Carson Experience will connect residents to the Games. As an official LA28 Venue City hosting multiple Olympic and Paralympic competitions, Carson's new initiative will engage residents through community events, activations and celebrations leading up to the 2028 Games while showcasing local pride and inspiring the next generation. Click image above to view full announcement. Vision - Carson: A thriving, diverse, destination city - a great place to live, work and play with an unlimited future. Mission - To serve and enhance the quality of life of residents and businesses through engagement and the efficient delivery of exceptional services. Contacts: Liselle DeGrave 9517640865 Liselle@RMGComm.com Source: City of Carson Distributed by: Reportable, Inc.
ENCINITAS, CA – June 18, 2026 Kiora Pharmaceuticals (NASDAQ: KPRX) today announced preclinical data showing that KIO-300, part of the company’s novel ion channel modulator platform, significantly suppressed seizure-associated electrophysiological activity in an ex vivo temporal lobe epilepsy (TLE) model. The findings were presented in a poster at the Epilepsy Foundation Pipeline Conference taking place June 18-19, 2026, in Leesburg, VA. To view the full announcement, including downloadable images, bios, and more, click here. Key Takeaways: Data demonstrated significant reduction in epileptiform activity The findings were reported at The Epilepsy Foundation Pipeline Conference taking place June 18-19, 2026 KIO-300 is the active pharmaceutical ingredient of KIO-301, Kiora’s ongoing Phase 2 clinical program in vision restoration in patients with gene mutation-agnostic Retinitis Pigmentosa Click image above to view full announcement. About Kiora Pharmaceuticals Kiora Pharmaceuticals is a clinical-stage biotechnology company developing advanced therapies for retinal disease. We target critical pathways underlying retinal diseases using innovative small molecules to slow, stop, or restore vision loss. KIO-301 is being developed initially for the treatment of retinitis pigmentosa, with potential to expand into choroideremia and Stargardt disease. It is a molecular photoswitch that has the potential to restore vision in patients with inherited and/or age-related retinal degeneration. KIO-104 is being developed for the treatment of macular edema due to retinal inflammation. It is a next-generation, non-steroidal, immuno-modulatory, and small-molecule inhibitor of dihydroorotate dehydrogenase (DHODH). In addition to news releases and SEC filings, we expect to post information on our website, www.kiorapharma.com, and social media accounts that could be relevant to investors. We encourage investors to follow us on X and LinkedIn as well as to visit our website and/or subscribe to email alerts. Forward-Looking Statements Some of the statements in this press release are "forward-looking" and are made pursuant to the safe harbor provision of the Private Securities Litigation Reform Act of 1995. These "forward-looking" statements include statements relating to, among other things, Kiora's ability to execute on development and commercialization efforts and other regulatory or marketing approval efforts pertaining to Kiora's development-stage products, including KIO-104 and KIO-301, as well as the success thereof, which such approvals or success may not be obtained or achieved on a timely basis or at all, the sufficiency of existing cash and short-term investments on hand to fund operations for specific periods, the timeline of anticipated readouts, the potential for pipeline expansion, the potential to add trial centers, expand the geographic footprint of trials and/or accelerate enrollment, the potential for KIO-301 and KIO-104 to address multiple indications, and the possibility of future global registration studies and commercialization. These statements involve risks and uncertainties that may cause results to differ materially from the statements set forth in this press release, including, among other things, the ability to conduct clinical trials on a timely basis, market and other conditions and certain risk factors described under the heading "Risk Factors" contained in Kiora's Annual Report on Form 10-K filed with the SEC on March 25, 2026 or described in Kiora's other public filings, including on Form 10-Q filed with the SEC on May 8, 2026. Kiora's results may also be affected by factors of which Kiora is not currently aware. The forward-looking statements in this press release speak only as of the date of this press release. Kiora expressly disclaims any obligation or undertaking to release publicly any updates or revisions to such statements to reflect any change in its expectations with regard thereto or any changes in the events, conditions, or circumstances on which any such statement is based, except as required by law. Contacts: Investors investors@kiorapharma.com Source: Kiora Distributed by: Reportable, Inc.
FOR IMMEDIATE RELEASE - JUNE 17, 2026 UGI Utilities is scheduled to begin system upgrades in Quakertown Borough and Richland Township on Monday, June 22, 2026. The work is part of UGI’s commitment to provide safe and reliable service and is an opportunity for some homes and businesses along the project route to convert to natural gas. To view the full announcement, including downloadable images, bios, and more, click here. Click image above to view full announcement. UGI Utilities, Inc. is a natural gas and electric utility company that serves more than 760,000 customers. Additional information about UGI Utilities, Inc. is available at www.ugi.com. Contacts: John Mason (610) 334-7135 jmason@ugi.com Source: UGI Utilities Distributed by: Reportable, Inc.
FOR IMMEDIATE RELEASE - JUNE 15, 2026 UGI Utilities just began system upgrades in Sellersville Borough, Bucks County. The work is part of UGI’s commitment to provide safe and reliable service and is an opportunity for some homes and businesses along the project route to convert to natural gas. To view the full announcement, including downloadable images, bios, and more, click here. Click image above to view full announcement. UGI Utilities, Inc. is a natural gas and electric utility company that serves more than 760,000 customers. Additional information about UGI Utilities, Inc. is available at www.ugi.com. Contacts: John Mason (610) 334-7135 jmason@ugi.com Source: UGI Utilities Distributed by: Reportable, Inc.
YUCCA VALLEY, CA - JUNE 10, 2026 The Keep A Breast Foundation, a 501(c)(3) nonprofit dedicated to breast cancer education and early detection, is back on the road with Vans Warped Tour 2026, and this year is bigger, bolder, and more community-driven than ever. Now in its 26th year, KAB has been part of the Warped Tour fabric since 1998, and 2026 marks the debut of a newly designed booth, a first-of-its-kind crypto partnership, and retail pre-party activations with Zumiez across all three U.S. stops. To view the full announcement, including downloadable images, bios, and more, click here. Key Takeaways: The Keep A Breast Foundation returns to Vans Warped Tour 2026 with a newly designed booth, a first-of-its-kind crypto partnership, and retail pre-party activations with Zumiez across all three U.S. stops. KAB embraces crypto philanthropy through a partnership with fomo and its role as the sole nonprofit beneficiary of the Boobillions ($boob) project on Solana, which has already generated nearly $100,000 for breast cancer prevention, education, and wellness. Fans in D.C. get exclusive meet and greets with Meet Me at The Altar and Daisy Grenade at the KAB booth and can purchase limited edition i love boobies! merchandise at the booth and at Zumiez while supplies last. Click image above to view full announcement. About The Keep A Breast Foundation The Keep A Breast Foundation is a 501(c)(3) nonprofit filling a critical gap in breast cancer education: reaching young people before they become patients. Founded in 2000, KAB empowers Gen Alpha, Gen Z and millennials with prevention-focused information through programs like the "i love boobies!" campaign and Keep A Breast app. Our mission is to reduce breast cancer risk and its impact globally through art, education, prevention, and action. About fomo fomo is a social media platform built to make crypto safe and simple for everyday users. Unlike traditional crypto platforms, fomo is community-driven and socially oriented, lowering technical barriers and structurally supporting nonprofit organizations through its model. Disclaimer: Cryptocurrency investments carry inherent risks. This press release does not constitute financial advice or an endorsement of any investment strategy. The Keep A Breast Foundation does not endorse or recommend any specific cryptocurrency investments. Contacts: Camille Lozano 6193726978 camille@keep-a-breast.org Source: Keep A Breast Foundation Distributed by: Reportable, Inc.
NEW YORK, N.Y., JUNE 11TH 2026 Wellness Index Report, the independent wellness ratings and education platform founded by Lindsay O'Neill-O’Keefe, has published a new Inside the Index feature spotlighting Nefense, a company helping redefine modern nasal wellness through innovative hypochlorous acid (HOCl) and xylitol-based products. To view the full announcement, including downloadable images, bios, and more, click here. Key Takeaways: Wellness Index Report publishes a new Inside the Index feature that spotlights Nefense and examines growing consumer interest in nasal health, respiratory hygiene, and drug-free alternatives to traditional care. The article reviews emerging research on hypochlorous acid, noting its antimicrobial and anti-inflammatory properties and potential uses across respiratory health and infection control. According to Wellness Index Report, Nefense offers doctor-recommended, ENT-approved, family-friendly HOCl and xylitol-based nasal solutions as a drug-free alternative to OTC sprays, formulated under the direction of Dr. Richard Downs, DDS. Click image above to view full announcement. About Wellness Index Report Wellness Index Report is an independent health and wellness education platform dedicated to helping consumers and medical providers identify evidence-informed wellness solutions through expert review, customer feedback, scientific evaluation, and ongoing performance monitoring. Through its Inside the Index editorial series, the organization highlights companies, practitioners, and technologies shaping the future of wellness and longevity. Contacts: Wellness Eternal — PR Team 914-846-9444 we@wellnesseternal.com Source: Newsworthy.ai Distributed by: Reportable, Inc.
NEW YORK, NY, JUNE 8, 2026 CryptoMondays Wall Street x ETHConf NYC, presented by 1inch and Troutman Pepper Locke, opened Ethereum Conference Week in New York City with a private, invitation-only gathering bringing together founders, investors, operators, attorneys, builders, and market leaders for substantive conversations around real world assets, institutional infrastructure, regulatory clarity, capital formation, and the practical next chapter of Web3 adoption. To view the full announcement, including downloadable images, bios, and more, click here. Key Takeaways: CryptoMondays Wall Street x ETHConf NYC opens Ethereum Conference Week in New York with an invitation-only gathering centered on real-world assets, institutional infrastructure, regulatory clarity, capital formation, and practical Web3 adoption. Presenting sponsor 1inch announces reDeFine Money, a limited-edition oral history of decentralized finance, and releases a free digital edition on the 1inch website with physical copies available only at select 1inch events. American Crypto Academy founder Jahon Jamali stresses in his keynote that education is essential to scaling institutional adoption of tokenized real-world assets and positions ACA as a central resource for professional and institutional markets. Click image above to view full announcement. About American Crypto Academy (ACA) American Crypto Academy delivers professional-grade crypto and blockchain education for institutional audiences, including CPAs, financial advisors, attorneys, and investment professionals. ACA’s curriculum bridges the knowledge gap between digital asset markets and the professionals navigating them, offering continuing education content built for the compliance, tax, accounting, and investment communities. About CryptoMondays Wall Street CryptoMondays Wall Street is a monthly, curated gathering at the intersection of digital assets, capital markets, institutional finance, and Web3 innovation. Part of the global CryptoMondays network — 70+ chapters, 14 countries, 150,000+ community members — the Wall Street edition is designed for high-signal conversation among founders, investors, operators, and policymakers shaping the institutional future of crypto. About 1inch 1inch is a leading DeFi aggregation and infrastructure protocol. The 1inch Network unites decentralized protocols whose synergy enables the most lucrative, fastest, and most protected operations in the DeFi space. About Troutman Pepper Locke Troutman Pepper Locke is a premier U.S.-based law firm with more than 1,600 attorneys across 30+ offices nationwide. The firm specializes in energy, financial services — including a dedicated focus on digital assets and blockchain development — health care, life sciences, insurance, private equity, and real estate. About Valmar Capital Valmar Capital is a leading multistrategy investment firm offering access to a diversified, actively-managed portfolio of systematic quantitative strategies that delivers consistent, uncorrelated absolute returns across all market cycles. About NFT VIP NFT VIP is a boutique event production and community activation company operating across crypto, culture, luxury, media, and institutional ecosystems. Founded by Julie Lamb, NFT VIP connects communities, brands, and ideas through premium experiences built for the attention economy. Contacts: Julie Lamb j@nft-vip.io Source: American Crypto Academy Distributed by: Reportable, Inc.
ST. LOUIS - JUNE 9, 2026 Ostara today announced a major advancement in fertilizer efficiency with a new, higher-analysis formulation of its high-efficiency CG P2X fertilizer. The increased 9-42-0 with 9 Mg analysis delivers nearly 30% more nitrogen and phosphorus while maintaining the product’s agronomic performance across diverse soils and growing conditions. To view the full announcement, including downloadable images, bios, and more, click here. Key Takeaways: Ostara today announced a major advancement in fertilizer efficiency with a new, higher-analysis formulation of its high-efficiency CG P2X fertilizer. By keeping nutrients available to the crop rather than the environment, CG P2X helps reduce nutrient losses that can contribute to water quality impairment and other environmental challenges while maximizing the value of every applied pound. The increased nutrient analysis enables growers to apply fewer pounds per acre, simplify logistics, and deliver more plant-available nutrients at an equal cost. Click image above to view full announcement. About Ostara | CG P2X Ostara is a phosphate technology company with a portfolio of phosphate fertilizers designed to deliver nutrients when and where crops need them most. Its flagship product, CG P2X™, the next evolution of Crystal Green®, is the first and only highly efficient phosphate fertilizer proven to release nutrients in response to crop demand. Ostara CG Pearl® is a phosphate fertilizer made through advanced nutrient recovery. Ostara CG Pearl for organic use is a phosphate fertilizer certified for organic production in Canada and the European Union. Ostara fertilizer products play a key role in the agriculture sector through a network of established retailers and distributors in North America and Europe. Learn more about Ostara at Ostara.com. Contacts: Erika Hanna erika@soldiercreekcommunications.com Source: Ostara Distributed by: Reportable, Inc.
REYKJAVIK, ICELAND / NEW YORK, NY — June 9, 2026 Treble Technologies, the pioneer in cloud-based acoustic simulation and synthetic audio data generation, and Hugging Face, the leading open platform for machine learning, today announced the launch of the Far Field ASR (FFASR) Leaderboard — the industry’s first open, community-driven benchmark designed to evaluate automatic speech recognition (ASR) models under realistic far-field acoustic conditions, which will improve end user experience when interacting with speech recognition engines in real-world deployments. To view the full announcement, including downloadable images, bios, and more, click here. Key Takeaways: Treble Technologies and Hugging Face launch the Far Field ASR (FFASR) Leaderboard, the first open, community-driven benchmark to evaluate ASR models under realistic far-field acoustic conditions on Hugging Face. The leaderboard enables developers and researchers to upload models and assess accuracy across reverberation, background noise, competing speech, and varying room acoustics using Treble’s virtual simulation to mirror real-world deployments. Treble and Hugging Face will host a joint webinar on Thursday, June 11, 2026 to explain the benchmark and participation, and the effort already draws interest from NVIDIA, IBM, and Cohere. Click image above to view full announcement. About Treble Technologies Treble is a leading-edge technology company revolutionizing how the world models sound. Utilizing its proprietary, cloud-based simulation engine and advanced SDK, Treble bridges the gap between physical acoustic measurements and scalable virtual prototyping. Treble’s solutions enable spatial audio research, precision building design, and high-throughput synthetic data generation for the world’s most advanced audio AI systems. Using the Treble platform, developers and device manufacturers can generate custom synthetic datasets and create application-specific acoustic evaluation scenarios tailored to their own deployment environments. For organizations seeking faster evaluation and training capabilities, Treble also provides access to pre-built far-field datasets designed for ASR development, testing, and model optimization. www.treble.tech About Hugging Face Hugging Face is the collaboration platform for the machine learning community. The Hugging Face Hub works as a central place where anyone can share, explore, discover, and experiment with open-source ML. HF empowers the next generation of machine learning engineers, scientists, and end users to learn, collaborate, and share their work to build an open and ethical AI future together. With the fast-growing community, some of the most used open-source ML libraries and tools, and a talented science team exploring the edge of tech, Hugging Face is at the heart of the AI revolution. Contacts: Vineet Ganju 1 949 294 5018 Vg@treble.tech Mike Sottak +1 650 248 9597 mike@wiredislandpr.com Source: Treble Technologies Distributed by: Reportable, Inc.
BOSTON, MA, MAY 27, 2026 The Deady Group, a Boston-based independent technology advisory firm, has sharpened its market focus on technology procurement, utility procurement, modernization strategy, and recurring spend management for regulated and innovation-driven organizations. To view the full announcement, including downloadable images, bios, and more, click here. Key Takeaways: The Deady Group is a Boston-based independent technology advisory firm focused on procurement, modernization, vendor evaluation, and recurring spend management across technology and utility environments. The firm gives regulated and innovation-driven organizations vendor-neutral guidance, structured evaluation, and broader market access across telecom, communications, cloud, cybersecurity, SaaS, AI, utilities, and related infrastructure. In suitable environments, recurring spend reduction opportunities may range from 15 percent to 30 percent through contract cleanup, vendor consolidation, service rationalization, benchmarking, and disciplined procurement. Click image above to view full announcement. The Deady Group is a Boston-based independent technology advisory firm guiding regulated and innovation-driven organizations through complex decisions across technology, utilities, vendors, and recurring spend. The firm brings vendor-neutral guidance, structured evaluation, and broader market access to procurement and modernization decisions that often span telecom, cloud, cybersecurity, software, AI, communications, and utility-related infrastructure. By combining procurement discipline with modernization judgment, The Deady Group gives leaders a clearer path to reduce risk, improve visibility, control costs, and align decisions with operational reality. Learn more at thedeadygroup.com Contacts: William Deady +1 617.221.7970 media@thedeadygroup.com Source: The Deady Group Distributed by: Reportable, Inc.
BURLINGTON, MA – JUNE 8, 2026 Lifordi Immunotherapeutics, Inc., a clinical-stage biotechnology company developing antibody-drug conjugates (ADCs) for the treatment of autoimmune and inflammatory disorders, presented first-in-human data for LFD-200, the Company’s novel subcutaneously (SC) administered ADC delivering a potent glucocorticoid (GC) directly to immune cells. Phase 1 data from healthy participants (HPs) presented at EULAR 2026 (European Congress of Rheumatology), in London, UK, June 3-6, 2026, showed LFD-200 was well tolerated and demonstrated dose-responsive anti-inflammatory activity with no impact on serum cortisol levels, a sensitive marker for systemic GC toxicity. Dosing patients with moderate to severe rheumatoid arthritis (RA) in the Phase 1 study is ongoing with data expected by year-end 2026. To view the full announcement, including downloadable images, bios, and more, click here. Key Takeaways: Initial Phase 1 data in showed LFD-200 was safe and well tolerated, and demonstrated anti-inflammatory effects without affecting cortisol Dosing in the Phase 1 study of LFD-200 in patients with Rheumatoid Arthritis is ongoing, with data expected by year-end 2026 First-in-human clinical data for LFD-200 was presented in a poster presentation at EULAR 2026 Click image above to view full announcement. About Lifordi Lifordi Immunotherapeutics, Inc. is a clinical-stage biotechnology company leading the way by leveraging the success of antibody-drug conjugates (ADCs) to develop treatments for autoimmune and inflammatory disorders. The Company’s lead ADC, LFD-200, is in a Phase 1 clinical trial for rheumatoid arthritis and demonstrated a favorable safety, PK and PD profile in healthy participants, including dose-responsive anti-inflammatory activity without systemic glucocorticoid toxicity (cortisol suppression). Lifordi has also applied its novel drug delivery approach to other diverse payloads, such as antisense oligonucleotides (ASOs), siRNA, and small molecules. As experienced drug developers in immunology and inflammatory diseases, together with expert clinical advisors and funding from ARCH Venture Partners, Atlas Venture, 5AM Ventures, and Sanofi Ventures, Lifordi is committed to changing how immune and inflammatory diseases are treated. For more information, please visit www.lifordi.com and follow us on LinkedIn. 1McClure et al., ACR 2025 Contacts: Theresa McNeely tmcneely@lifordi.com Source: Lifordi Distributed by: Reportable, Inc.
Dubuque, Iowa, June 4, 2026 Nefense®, a pioneer in advanced clinical hygiene and airway health solutions, today announced the official launch of its highly anticipated Hypochlorous Acid (HOCl) nasal spray line. This comprehensive product expansion introduces an age-specific approach to airway health, respiratory hygiene, and nasal wellness, providing safe and effective nasal care solutions for adults, children, and infants. To view the full announcement, including downloadable images, bios, and more, click here. Key Takeaways: Nefense launches a new hypochlorous acid nasal spray line that delivers an age-specific respiratory defense portfolio for adults, children, and infants. The flagship Hyponasal spray provides a gentle, clinical-grade biocleanse that flushes irritants, delivers immediate soothing relief, and supports natural respiratory defenses without harsh chemicals or steroids. Powered by hypochlorous acid, the formulations deliver broad-spectrum antimicrobial and anti-inflammatory action that neutralizes bacteria and viruses, helps prevent upper respiratory infections, and combats seasonal allergies. Click image above to view full announcement. About Nefense® Nefense®, Natural Wellness & Defense, is dedicated to developing advanced, science-driven health and hygiene products. Working in collaboration with doctors and ENT specialists, Nefense focuses on creating innovative solutions that bridge the gap between daily hygiene, airway health, restorative sleep, and overall wellness. Many clinics and practices nationwide offer in-store purchases of the Nefense nasal spray family, including XyloClean, a xylitol-based nasal spray designed to help moisturize and rebalance the nasal passages. Through its growing portfolio of clinically inspired products, Nefense remains committed to helping people breathe better and live healthier. Contacts: Sumit Verma (608) 330-1011 info@nefense.com Source: Newsworthy.ai Distributed by: Reportable, Inc.
BOSTON — JUNE 5, 2026 — The PR Club welcomed more than 150 public relations and communications professionals to the Museum of Science for the 58th Annual Bell Ringer Awards, returning to the iconic Boston venue for the second consecutive year. The evening was hosted by Edgar B. Herwick III, the Emmy Award-winning GBH host and reporter behind the “Curiosity Desk” series and co-host of “The Culture Show.” To view the full announcement, including downloadable images, bios, and more, click here. Key Takeaways: 360PR+ wins the Super Bell Award for Bob's Red Mill's 'Moregetherness' campaign. The campaign first earned Gold Bells in two categories before advancing to win the evening's top honor. The John J. Molloy Crystal Bell Lifetime Achievement Award was presented to Kathy Wilson of Tier One Partners, honoring a distinguished career and an extensive track record of contributions to the New England communications community. The Ringer Award, recognizing a mid-career professional, was presented to Sam Powers of Walker Sands. The Striker Award, celebrating early-career achievement, went to Aidan Poole of Walker Sands. The Carillonneur Award for Best Team Culture, recognizing a public relations or communications organization, was awarded to Randstad Digital | powered by Torc. Click image above to view full announcement. About PR Club Founded in 1948, the PR Club (formerly the Publicity Club of New England) strives to promote and encourage involvement in the communications industry and specifically the professions of public relations, promotions, and marketing. Get additional information about monthly PR Club programs, social and networking events, the Club blog and the Bell Ringer Awards at prclub.org, and follow on LinkedIn and Instagram. About the Bell Ringer Awards The Bell Ringer Awards recognize public relations and communications work that demonstrates excellence in creative planning and superior execution to achieve a high degree of success in reaching predetermined objectives. Open to all New England practitioners, the program, now in its 58th year, celebrates the extraordinary work of the region's communications professionals. Contacts: Kaitlynn Cooney admin@prclub.org Source: The PR Club Distributed by: Reportable, Inc.
DALLAS, TX -- JULY 4, 2026 DALLAS, TX -- June 4, 2025 -- Cingulate Inc. (NASDAQ: CING): Stonegate Capital Partners updates coverage on Cingulate Inc. (NASDAQ: CING). Cingulate’s latest update shifts the near-term CTx-1301 setup from a PDUFA driven approval event to a CMC-driven resubmission process, while leaving the core product thesis intact based on the information disclosed. The FDA issued a Complete Response Letter for the CTx-1301 NDA focused on specific CMC information requests, with no current clinical safety or efficacy concerns identified. In our view, the key read-through is timing rather than product viability, as the path forward now depends on completing the requested CMC work, resubmitting to FDA, and moving through the next review cycle. Importantly, Cingulate disclosed nearly $30M of cash on hand, which management believes is sufficient to address the FDA’s requests, execute the resubmission process, and continue pre-commercial activities into 2027. To view the full announcement, including downloadable images, bios, and more, click here. Key Takeaways: Balance sheet now supports execution. With C$51.1M in cash and C$51.0M of equity, American Tungsten is funded to advance IMA without near-term capital pressure. IMA is moving from concept to execution. Q1 spend of C$4.8M on exploration/evaluation shows capital is being deployed directly into underground access, drilling, assays, and field work. Uplist improves investability. The move to the TSXV on May 29, 2026 expands market visibility and should improve institutional access as the story matures. Click image above to view full announcement. About Stonegate Stonegate Capital Partners is a leading capital markets advisory firm providing investor relations, equity research, and institutional investor outreach services for public companies. Our affiliate, Stonegate Capital Markets (member FINRA) provides a full spectrum of investment banking services for public and private companies. Contacts: Stonegate Capital Partners (214) 987-4121 info@stonegateinc.com Source: Stonegate, Inc. Distributed by: Reportable, Inc.
DALLAS, TX -- JUNE 4, 2026 DALLAS, TX -- June 4, 2026 -- American Tungsten Corp. (CSE: TUNG): Stonegate Capital Partners updates coverage on American Tungsten Corp. American Tungsten’s capital position and operating cadence have improved materially as it advances IMA. As of March 31, 2026, the Company reported C$51.1M of cash, C$52.5M of total assets, and C$51.0M of shareholders’ equity, following the March 2026 C$40.0M bought-deal financing. Q1 2026 net loss was C$5.8M, primarily reflecting C$4.8M of exploration and evaluation expense at IMA, including underground access, drilling, assays, and related field work. Subsequent to quarter-end, the Company received TSXV approval and began trading on the TSXV under “TUNG” on May 29, 2026, with the CSE delisting effective market close on May 28, 2026. In our view, the story has evolved from a better-capitalized restart concept into a more active two-track development platform centered on IMA: Phase I tailings evaluation / potential processing and Phase II underground mine restart. To view the full announcement, including downloadable images, bios, and more, click here. Key Takeaways: TUNG is now better funded and more active, with C$51.1M of cash and a 35,000 ft drill program supporting a transition from restart concept to resource-definition platform. Tailings have become a standalone value driver, with 35/35 boreholes intersecting tungsten mineralization and 190,000–200,000 m³ of estimated tailings volume supporting a potential lower-capital production path. The near-term setup is increasingly catalyst-rich, with underground drilling, tailings resource work, metallurgy, permitting, and a C$4.91 midpoint valuation anchoring the IMA development thesis. Click image above to view full announcement. About Stonegate Stonegate Capital Partners is a leading capital markets advisory firm providing investor relations, equity research, and institutional investor outreach services for public companies. Our affiliate, Stonegate Capital Markets (member FINRA) provides a full spectrum of investment banking services for public and private companies. Contacts: Stonegate Capital Partners (214) 987-4121 info@stonegateinc.com Source: Stonegate, Inc. Distributed by: Reportable, Inc.
NEW YORK, NY JUNE 3, 2026 The latest Wellness Index Report reveals a significant evolution in consumer wellness priorities, showing growing interest in understanding the root causes of health concerns rather than focusing solely on lifespan and longevity. To view the full announcement, including downloadable images, bios, and more, click here. Key Takeaways: The Wellness Index Report reveals a major shift in consumer wellness priorities toward understanding root causes and improving overall quality of life over simply extending longevity. The report identifies three emerging trends: growing use of personalized diagnostics to uncover root causes, rising demand for non-pharmaceutical pain management, and increasing emphasis on human connection, purpose, and mental wellness. The report concludes that the future of wellness favors an integrated model that combines personalized diagnostics, preventive health strategies, emotional resilience, pain management, and human connection. Click image above to view full announcement. About the Wellness Index Report The Wellness Index Report is a practitioner-led evaluation platform that assesses wellness providers and technologies through a four-step process including expert nomination, customer feedback, clinical review, and ongoing rating analysis. It is designed to provide transparent, third-party validation in the rapidly growing wellness and biohacking industry. Contacts: Wellness Eternal — PR Team 914-846-9444 we@wellnesseternal.com Source: Newsworthy.ai Distributed by: Reportable, Inc.
DALLAS, TX -- JUNE 2, 2026 DALLAS, TX -- June 2, 2026 -- SES AI Corp. (NYSE: SES): Stonegate Capital Partners Initiates Coverage on SES AI Corp. (NYSE: SES). SES’ 1Q26 update further shifts the story from EV battery development toward a commercialization model led by ESS, with drone cells, materials, and Molecular Universe adding clearer 2H26/2027 revenue paths. Revenue beat expectations, though Q1 benefited from ~$1.5M of 4Q25 revenue shifting into the period, so the better read is not run-rate extrapolation but improved mix, reaffirmed FY26 guidance, and better visibility into drone qualification, cost reductions, and AI-enabled product differentiation. To view the full announcement, including downloadable images, bios, and more, click here. Key Takeaways: SES is shifting from EV R&D toward commercialization, with ESS anchoring FY26 revenue and drone cells/materials adding clearer 2H26 and 2027 growth paths. 1Q26 revenue beat was helped by timing, but stronger gross margin, improved mix, and reaffirmed $30M–$35M guidance support execution credibility. Drone cells are the key upside variable, with NDAA-compliant samples shipping, defense interest building, and qualification potentially converting into fuller 2027 deliveries. Click image above to view full announcement. About Stonegate Stonegate Capital Partners is a leading capital markets advisory firm providing investor relations, equity research, and institutional investor outreach services for public companies. Our affiliate, Stonegate Capital Markets (member FINRA) provides a full spectrum of investment banking, equity research and capital raising for public and private companies. Contacts: Stonegate Capital Partners (214) 987-4121 info@stonegateinc.com Source: Stonegate, Inc. Distributed by: Reportable, Inc.
SALINAS, CA - JUNE 2, 2026 Reservoir announced a new participation structure across its agricultural innovation network designed to lower barriers to field testing, equipment access and commercialization support to accelerate rugged AI and agricultural innovation. Alongside its existing paid Member and Resident tiers, Reservoir now supports a free Associate tier that unlocks on-farm testing access to emerging projects and researchers, thus drastically lowering the barrier to entry for agricultural innovation. To view the full announcement, including downloadable images, bios, and more, click here. Key Takeaways: Alongside its existing paid Member and Resident tiers, Reservoir now supports a free Associate tier that unlocks on-farm testing access to emerging projects and researchers, thus drastically lowering the barrier to entry for agricultural innovation. “AgTech wins in the field,” said Matthew Hoffman, general partner and head of Reservoir Farms. “Today, too many technology startups burn through capital working on problems that are misaligned with growers and industry needs...We get startups into the field alongside industry experts as soon as they sign up. This is good for startups, good for investors, and good for growers.” “We see water security as critical infrastructure for the 21st century, and agriculture is on the front lines of that shift,” said Dacia Leon, PhD, co-founder and CEO of Supercool Earth, a startup developing a novel approach to cloud seeding to address water scarcity. “By joining the Reservoir community, we can easily explore new opportunities alongside the people who feel these challenges first..." Click image above to view full announcement. Reservoir is an agricultural innovation center and venture capital fund focused on helping agtech startups succeed where agriculture happens—in the field. Reservoir Farms are the world’s first on-farm robotics innovation centers, starting in the Salinas Valley and expanding to other key regions across California and the American West. Reservoir VC backs startups solving real problems in high-value crops and the rugged physical AI stack. By combining R&D space, hands-on grower input, and early-stage capital, Reservoir helps turn promising ideas into tools for the growers who feed the world. Learn more at https://reservoir.co. Contacts: Jennifer Goldston, AgTech PR jennifer@agtechpr.com Source: Reservoir Distributed by: Reportable, Inc.
CHAPEL HILL, N.C. JUNE 2, 2026 iOrganBio, an innovator in intelligent cell manufacturing that is redefining how human cells are engineered and reliably produced at scale for research and therapeutic applications, including FDA-aligned New Approach Methodologies (NAMs), today announced the appointment of Zhiping Pang, M.D., Ph.D., to its Scientific Advisory Board. Dr. Pang is one of the leading experts in human neuron biology, synaptic function, and the molecular mechanisms underlying neuropsychiatric and metabolic disorders, with more than 140 publications in top journals including Nature, Science, Nature Neuroscience, and Nature Metabolism. He is the Henry Rutgers Professor of NeuroMetabolism and Professor of Neuroscience and Cell Biology at Rutgers Robert Wood Johnson Medical School, and the Director of the Center for NeuroMetabolism at Rutgers Health. To view the full announcement, including downloadable images, bios, and more, click here. Key Takeaways: iOrganBio adds a leading expert in human neuron and synaptic biology to its Scientific Advisory Board. Pang’s expertise strengthens the scientific breadth advising iOrganBio as the field moves toward more human‑relevant, non‑animal systems. The appointment bolsters iOrganBio’s position as a leader in AI-enabled, scalable, human cell and organoid production. Click image above to view full announcement. About iOrganBio iOrganBio is transforming human cell production with CellForge™, its AI-powered platform for consistent, scalable, and intelligent manufacturing of cells and organoids for in vitro modeling and cell therapies. By applying engineering precision to biology, CellForge uses AI and automation to guide cell development and make real-time adjustments aligned with defined biological profiles. At the core of the platform is iOrganBio’s functional human CellAtlas™, a comprehensive reference built from single-cell and multi-omics data that provides the digital blueprints for each cell type. This smart, closed-loop process delivers the accuracy, efficiency, and quality partners need to turn scientific ideas into breakthroughs, accelerating disease modeling, regenerative medicine, and drug development. For more information, visit iOrgan.Bio or follow us on LinkedIn. Contacts: Michelle Linn michelle@linndencom.com Source: iOrganBio Distributed by: Reportable, Inc.
JUNE 1, 2026 DALLAS, TX -- June 1, 2026 -- Initiates Coverage on Postal Realty Trust Inc. (NYSE: PSTL): Stonegate Capital Partners Initiates Coverage on Postal Realty Trust Inc. (NYSE: PSTL). PSTL’s 1Q26 update improved the setup by increasing forward revenue visibility and accelerating acquisition capacity at the same time. In our view, the thesis is becoming easier to underwrite, as the lease platform is producing clearer internal growth through mark-to-market resets and escalators, while improved capital access is adding a more active external growth leg. The next few quarters should be defined by acquisition conversion, continued lease book modernization, and leverage-neutral funding. To view the full announcement, including downloadable images, bios, and more, click here. Key Takeaways: The thesis is shifting from stability to visible growth, with rent resets, escalators, and lease-term extension improving forward AFFO visibility. Acquisition capacity is reaccelerating, as $130-$140M guidance, 7.4% cap-rate deployment, and forward equity support leverage-neutral external growth. The earnings base is becoming cleaner, with limited holdover noise, 99.8% occupancy, and a valuation framework supporting a $26.08 midpoint. Click image above to view full announcement. About Stonegate Stonegate Capital Partners is a leading capital markets advisory firm providing investor relations, equity research, and institutional investor outreach services for public companies. Our affiliate, Stonegate Capital Markets (member FINRA) provides a full spectrum of investment banking, equity research and capital raising for public and private companies. Contacts: Stonegate Capital Partners (214) 987-4121 info@stonegateinc.com Source: Stonegate, Inc. Distributed by: Reportable, Inc.
DALLAS, TX -- JUNE 1, 2026 DALLAS, TX -- June 1, 2026 -- Initiates Coverage on Creative Media & Trust Corp. (NASDAQ: CMCT): Stonegate Capital Partners Initiates Coverage on Creative Media & Trust Corp. (NASDAQ: CMCT). CMCT’s 1Q26 update shifts the story from balance sheet repair to FFO conversion. Reported results remained noisy given the late-quarter preferred redemption, but the Company has now redeemed $396.2M of preferred stock since September 2024, sold First Western, retired its recourse credit facility, and moved closer to its long-term target capital structure. The March redemption of $242.8M is expected to improve FFO by approximately $16.0M annually beginning in 2Q26, making the next several quarters a cleaner test of post-recapitalization earnings power. The key equity driver is now whether lower preferred dividends, improving multifamily occupancy, completed hotel renovations, and refinancing activity translate into visible FFO recovery. To view the full announcement, including downloadable images, bios, and more, click here. Key Takeaways: Recapitalization shifts the story to FFO recovery. CMCT has redeemed $396.2M of preferred stock, retired its recourse facility, and sold First Western, making FFO conversion the key equity driver. 2Q26 is the cleaner baseline. 1Q26 was distorted by the late-March redemption, office items, hotel disruption, and lost lending NOI; the $16.0M annual FFO benefit begins in 2Q26. Operating upside depends on multifamily, hotels, and refinancing. Multifamily occupancy is improving, hotel renovations are complete, and refinancing/liquidity execution will drive the next phase of the thesis. Click image above to view full announcement. About Stonegate Stonegate Capital Partners is a leading capital markets advisory firm providing investor relations, equity research, and institutional investor outreach services for public companies. Our affiliate, Stonegate Capital Markets (member FINRA) provides a full spectrum of investment banking, equity research and capital raising for public and private companies. Contacts: Stonegate Capital Partners (214) 987-4121 info@stonegateinc.com Source: Stonegate, Inc. Distributed by: Reportable, Inc.
LOS ANGELES, MAY 26, 2026 As Freedom 250 leads the celebration of 250 years of American Independence, President Trump has invited Americans to pray for our country. To give Americans a platform to join together in prayer, Freedom 250 has partnered with PRAY.COM to create AmericaPrays.com – the central digital hub to unite millions of Americans in prayer as the nation celebrates its 250th birthday. To view the full announcement, including downloadable images, bios, and more, click here. Key Takeaways: Freedom 250 partners with PRAY.COM to launch AmericaPrays.com as the central digital hub uniting millions in prayer during the nation’s 250th anniversary. The America Prays initiative brings together more than 140 faith organizations with a combined reach exceeding 1.2 billion, with PRAY.COM serving as its official technology platform. AmericaPrays.com features a prayer wall, historic prayer content from the National Archives, and resources to help people form local prayer groups, share answered prayers, and participate in the movement. Click image above to view full announcement. PRAY.COM is the official technology provider for the America Prays 250 initiative, providing the digital platform at AmericaPrays.com that unites millions of Americans in prayer for the nation's 250th anniversary. Founded in 2016 with a mission to grow faith and cultivate community, PRAY.COM serves as a trusted technology partner for thousands of churches and ministries while reaching millions of individuals through daily devotionals, pastoral content, and biblically-grounded resources. The company is led by founders Steve Gatena, Michael Lynn, Ryan Beck, and Matthew Potter. Contacts: Jason Rosoff press@pray.com Source: PRAY.COM Distributed by: Reportable, Inc.
London, UK, Tuesday May 26 Europe’s cannabis economy has long been described as a sleeping giant. A new international report suggests that the European sleeping giant may finally be waking up. To view the full announcement, including downloadable images, bios, and more, click here. Key Takeaways: A new report released at the Cannabis Europa 2026 says Europe’s cannabis industry is entering a major growth phase, driven by expanding medical cannabis programs, telemedicine adoption, international trade, and stricter pharmaceutical manufacturing standards across the EU and UK. The report highlights Germany as Europe’s cannabis reform leader while noting rapid UK medical cannabis growth through private clinics and telemedicine. It also says EU GMP compliance, international imports, and increasing price competition are reshaping the European cannabis market. Industry analysts behind the report believe the next three to five years will be critical for Europe’s cannabis economy as countries refine regulations, expand patient access, and compete within an increasingly globalized and operationally complex cannabis supply chain. Click image above to view full announcement. About GCNC The Global Cannabis Network Collective (GCNC) is a membership-based organization connecting cannabis operators, investors, and service providers worldwide. GCNC facilitates strategic connections, market intelligence, and drives international deal flow across the global cannabis supply chain. For more information, visit GCNC.Global. Continue the conversation on LinkedIn. About Whitney Economics Portland, Oregon-based Whitney Economics is a global leader in cannabis and hemp business consulting, data, and economic research, supporting hemp and cannabis operators, investors and regulators. Whitney Economics does not take a position on the legalization of cannabis, nor does it take positions on proposed legislation. Visit WhitneyEconomics.com. Contacts: Shawna Seldon (917) 971-7852 shawna@themaverickpr.com Source: Newsworthy.ai Distributed by: Reportable, Inc.
PALM BEACH, FL AND BELLEVUE, WA- MAY 21, 2026 Ashby & Gabriel, Advaiya, and Mellifluous Fusion partner to offer marketing, business technology, and AI-based engagement services to the growing Fusion Energy ecosystem. With AI growing, and the world’s population growing and evolving, energy has become the watchword, and the fusion industry has raised the stakes on providing abundant, clean, baseload power for AI and all other workloads and societal needs. To view the full announcement, including downloadable images, bios, and more, click here. Key Takeaways: Ashby & Gabriel, Advaiya, and Mellifluous Fusion in Partnership Fusion energy industry growing rapidly and needs marketing support Great marketing for the fusion ecosystem requires deep knowledge of the science and technology Click image above to view full announcement. About Asbhy & Gabriel Ashby & Gabriel is a full-service marketing agency dedicated to helping mission-driven organizations amplify their impact. By combining proven strategies with compelling storytelling, data-driven insights, and innovative branding, we equip our clients with the tools they need to drive meaningful change. Our client-centered model often functions as an extension of in-house marketing teams, providing the strategic expertise and execution needed to achieve measurable results. At Ashby & Gabriel, we believe marketing is more than promotion; it’s a catalyst for transformation. Learn more at www.ashbyandgabriel.com. About Advaiya Advaiya Solutions is a leading technology company that empowers businesses to thrive in the digital age. Advaiya specializes in delivering innovative solutions to help organizations in their technology needs around work and operations, customer engagement, and leveraging data. Advaiya helps organizations enhance customer engagement, streamline operations, and drive growth through tailored solutions while understanding business context and needs. Advaiya is the creator of Peripheral Automation; this framework allows businesses to incrementally adopt AI and automation by focusing on tasks and processes surrounding core business data, minimizing disruption, and maximizing efficiency. www.advaiya.com About Mellifluous Fusion Nuclear fusion promises the world a source of abundant and clean baseload power. As the demands of technological societies increase and as new workloads like AI boom, Fusion is at the fore. Great strides have been made and still there is a distance to go, to make this breakthrough form of energy commercially viable at scale. Fusion is a convergence point between science, technology, economics, politics, innovation, and sociology. To get where the world needs us to get, we need to create the finest narratives, backed by science and engineering, and to stake fusion’s claim as fundamental to humanity’s future. Mellifluous Fusion is dedicated to drive that narrative through ideation, production, strategy, and collaboration. Welcome to Mellifluous Fusion. www.mellifluousfusion.ai Contacts: Romi Mahajan, CEO romi@thekkmgroup.com Source: Mellifluous Fusion Distributed by: Reportable, Inc.
INDIANAPOLIS, INDIANA — WEDNESDAY, MAY 20, 2026 Advanced Agrilytics, a leading agronomy technology company delivering sub-acre agronomic intelligence at scale, today introduced TerraSIGNAL ™ , an AI-native agronomic decision software platform to help growers make faster, more confident decisions across every acre. To view the full announcement, including downloadable images, bios, and more, click here. Key Takeaways: TerraSIGNAL ™ , an AI-native agronomic decision software platform will help growers make faster, more confident decisions across every acre. TerraSIGNAL is built on Advanced Agrilytics’ field-proven, proprietary sub-acre analytical framework and deterministic agronomic science, backed by more than 20 U.S. patents and 15 years of field-level agronomic research and operational data. Over a documented 10-year study period, fields managed using the Advanced Agrilytics platform demonstrated an average corn yield increase of 20 bushels per acre. Click image above to view full announcement. Advanced Agrilytics is a leading agronomy technology company delivering sub-acre agronomic intelligence at scale. Through a flexible ecosystem of data, software, and value-added services, we empower growers, consultants, retailers, and manufacturers to make smarter, more profitable decisions. Our business spans four complementary areas: agronomy services, software licensing, applied research, and sustainability and funding support, including Section 180 residual fertility valuation reports. Our proprietary spatial agronomy methodology is proven to increase yield consistency, reduce variability, and enhance long-term resilience across every acre. Founded in 2015 in Huntington, Indiana, and headquartered in Indianapolis, we remain committed to helping partners improve profitability and sustainability while building a legacy for generations to come. Advanced Agrilytics is a portfolio company of Paine Schwartz Partners, a global leader in sustainable food chain investing. Contacts: Erika Hanna Erika@SoldierCreekCommunications.com Source: Advanced Agrilytics Distributed by: Reportable, Inc.
FOR IMMEDIATE RELEASE - MAY 19, 2026 UGI Utilities just began system upgrades in Hazle Township, Luzerne County. The work is part of UGI’s commitment to provide safe and reliable service and is an opportunity for some homes and businesses along the project route to convert to natural gas. To view the full announcement, including downloadable images, bios, and more, click here. Click image above to view full announcement. UGI Utilities, Inc. is a natural gas and electric utility company that serves more than 760,000 customers. Additional information about UGI Utilities, Inc. is available at www.ugi.com. Contacts: John Mason (610) 334-7135 jmason@ugi.com Source: UGI Utilities Distributed by: Reportable, Inc.
LOS ANGELES, CA - MAY 19, 2026 - Voker, the agent analytics platform for AI product teams, has announced the disclosure of $2.2 million in pre-Seed funding from Y Combinator and FundersClub. The investment will accelerate Voker's mission to make every AI agent interaction measurable, explainable, and aligned with real business outcomes.In a world where every agent says “Ask me anything,” few deliver on that promise today. As agents move from prototype to production, teams face a universal challenge: there isn’t a structured way to understand whether their agents are working, improving, or driving the outcomes they were built to deliver. Traditional monitoring tools were designed for SaaS, not the conversational behavior of LLM-powered agents. Without the insights that Voker provides, product teams cannot measure performance, prove ROI, or iterate with confidence.“AI agents are shipping every day, but companies have no way to know if the agents are actually working; which leads to guessing, over-correcting, and losing users to bad experiences,” said Tyler Postle, Co-Founder and CEO at Voker. “We built Voker because the analytics layer for AI agents simply does not exist; and without it even the best-intentioned teams are flying blind. This funding lets us move faster to give product teams the visibility they need to build agents that actually deliver."Voker provides complete visibility into how agents perform across real user interactions. Product managers can learn the intents of users and track corrections and frustrations; engineers can stop reactive debugging; and analysts gain a structured dataset, and all without manual data wrangling. With user intent detection, queryable conversation timelines, and an Outcome Correlation Engine, Voker helps teams understand which agent behaviors drive results.“You can't improve what you can't measure. The AI agent market is exploding right now, and the companies that are best at instrumenting and improving their agents will win against those that don’t,” said Dalton Caldwell, Co-Founder of Standard Capital and Partner Emeritus at Y Combinator. “Voker is building the analytics layer that every agent-powered business needs, and that is why I funded them at Y Combinator."The best AI product teams are iterating on their LLM stack constantly, which is why Voker is provider agnostic. The lightweight Voker SDK can be instrumented across any framework, with dedicated wrappers for all the leading providers.“When customers flood our Slack with the same agent issue, we're scrambling with what's going on, how widespread, how bad? We gave up on building evals: it's an endless reactive battle you can't win, said Ves Stoyanov, CoFounder and Head of AI at Lightfield. “Voker shows us agent performance and emergent user behavior before it lands as a customer complaint.” To view the full announcement, including downloadable images, bios, and more, click here. Key Takeaways: Voker raises $2.2 million in pre-seed funding from Y Combinator and FundersClub to accelerate its mission to make every AI agent interaction measurable, explainable, and aligned with real business outcomes. The platform gives product teams complete visibility into AI agent performance across real user interactions with features including user intent detection, queryable conversation timelines, and an Outcome Correlation Engine. Click image above to view full announcement. About Voker Voker is the Agent Analytics Platform for AI product teams building the best agents. Voker transforms agent and user interactions into structured analytics that anyone on your team can leverage without digging through logs. It provides complete visibility into how agents perform across real user interactions, letting teams define metrics that tie directly to business outcomes. With user intent detection, queryable conversation timelines, and an Outcome Correlation Engine, Voker helps product managers, engineers, analysts, and executives collaborate to build better agents - measurable, explainable, and aligned with real results. Leading AI companies like Lightfield use Voker to build better agents. For more information, visit https://voker.ai/ Contacts: press@voker.ai Source: Voker Distributed by: Reportable, Inc.
DALLAS, TX -- MAY 18, 2026 DALLAS, TX -- May 18, 2026 -- Nine Energy Services (NYSEAM: NINE): Stonegate Capital Partners Initiatiates Coverage on Nine Energy Services (NYSEAM: NINE). NINE’s 1Q26 print marked an important transition quarter as the Company emerged from bankruptcy and reset its financial foundation. GAAP comparability was limited by Chapter 11 emergence and fresh-start accounting, while adjusted EBITDA was burdened by severe January/February weather and a $5.5M non-cash inventory write-down that management did not add back. The read-through was positive, management stated NINE had no material customer or vendor losses, and pricing across technology and service offerings was mostly unchanged q/q, with service-line pricing largely stable versus 2025 exit rates. For an OFS company exiting restructuring, stable pricing matters because it indicates 1Q margin pressure was driven by utilization disruption and timing rather than customer concessions or competitive share loss. To view the full announcement, including downloadable images, bios, and more, click here. Key Takeaways: 2Q guidance is the cleaner benchmark for post-emergence earnings power. 1Q was distorted by fresh-start accounting, weather, and a $5.5M inventory write-down. Commercial stability was a critical indicator. No material customer/vendor losses and stable pricing suggest restructuring did not impair market relevance. Upside is more tied to normalization and mix than broad activity recovery. Gas-basin exposure, completion tools, and international growth provide the clearest EBITDA levers. Click image above to view full announcement. About Stonegate Stonegate Capital Partners is a leading capital markets advisory firm providing investor relations, equity research, and institutional investor outreach services for public companies. Our affiliate, Stonegate Capital Markets (member FINRA) provides a full spectrum of investment banking, equity research and capital raising for public and private companies. Contacts: Stonegate Capital Partners (214) 987-4121 info@stonegateinc.com Source: Stonegate, Inc. Distributed by: Reportable, Inc.
DALLAS, TX -- MAY 15, 2026 DALLAS, TX -- May 15, 2026 -- Fold Holdings Inc. (NASDAQ: FLD): Stonegate Capital Partners Updates Coverage on Folding Holdings Inc. (NASDAQ: FLD). Fold’s 1Q26 reflected bitcoin-market-driven pressure on activity, but the quarter did not change the core thesis; it shifted the FY26 focus toward conversion and scaling across products now in market. Revenue declined 21.1% y/y to $5.6M as transaction volume fell 32% y/y to $172M, while verified accounts approached 85K with close to 2K net adds. Net loss was $(29.2)M and adj. EBITDA was $(5.8)M, though GAAP results were affected by bitcoin treasury fair value changes and financing-related items. Operating expenses declined 19% y/y to $13.4M, supported by lower direct costs, lower stock-based compensation, and lower professional fees. Management noted February marked the bottom across most core KPIs, with early improvement as bitcoin recovered. We view 1Q26 as market driven pressure in transaction-linked activity, while Fold’s broader platform strategy moved closer to commercial validation. To view the full announcement, including downloadable images, bios, and more, click here. Key Takeaways: 1Q26 advanced Fold’s transition toward platform-led monetization. Account growth, opex discipline, and concurrent product launches support a broader revenue model beyond transaction activity. Credit card execution is the primary FY26 catalyst. With 1,000+ cards live and an ~80K waitlist, cohort spend, engagement, credit performance, and funding capacity will drive the setup. Capital structure simplification improves strategic flexibility. Extinguishing the convertible notes, while retaining bitcoin treasury exposure, strengthens Fold’s ability to scale credit, gift card, and business channels. Click image above to view full announcement. About Stonegate Stonegate Capital Partners is a leading capital markets advisory firm providing investor relations, equity research, and institutional investor outreach services for public companies. Our affiliate, Stonegate Capital Markets (member FINRA) provides a full spectrum of investment banking, equity research and capital raising for public and private companies. Contacts: Stonegate Capital Partners (214) 987-4121 info@stonegateinc.com Source: Stonegate, Inc. Distributed by: Reportable, Inc.
DALLAS, TX -- MAY 15, 2026 DALLAS, TX -- May 15th, 2026 -- StimCell Energetics Inc. (STME): Stonegate Initiates Coverage on StimCell Energetics Inc. (STME). StimCell is a single-product company focused on eBalance®. Rather than managing a broad portfolio, the Company is centered on advancing one core platform. The current emphasis appears to be on redesigning eBalance into a compact consumer unit optimized for home use, and the Company’s SEC filings state that StimCell is focused on the discovery, development, and commercialization of both therapeutic and non-therapeutic products that promote general wellness To view the full announcement, including downloadable images, bios, and more, click here. Key Takeaways: STME is a focused, single-product story centered on eBalance, with the near-term investment case tied to completing the home-use redesign and preparing for commercialization. The product narrative is built around non-invasive microcurrent stimulation and biofeedback, which could create value if eBalance is validated as both a wellness device and a tool for monitoring the body’s response. Early company-reported data and new mechanistic research are encouraging but still preliminary, making further validation critical to investor confidence and long-term adoption. Click image above to view full announcement. Stonegate Capital Partners is a leading capital markets advisory firm providing investor relations, equity research, and institutional investor outreach services for public companies. Our affiliate, Stonegate Capital Markets (member FINRA) provides a full spectrum of investment banking, equity research and capital raising for public and private companies. Contacts: Stonegate Capital Partners (214) 987-4121 info@stonegateinc.com Source: Stonegate, Inc. Distributed by: Reportable, Inc.
FOR IMMEDIATE RELEASE - MAY 15, 2026 UGI Utilities, Inc. (UGI) announced its purchased gas cost rates will not change on June 1, 2026. To view the full announcement, including downloadable images, bios, and more, click here. Click image above to view full announcement. UGI Utilities, Inc. is based in Denver, Pennsylvania and serves more than 760,000 natural gas and electric customers in 46 counties in Pennsylvania and one county in Maryland. Additional information about UGI is available at www.ugi.com on Facebook at www.facebook.com/ugiutilities; and X at www.twitter.com/ugi_utilities. Contacts: John Mason (610) 334-7135 jmason@ugi.com Source: UGI Utilities Distributed by: Reportable, Inc.
DALLAS, TX -- MAY 14, 2026 DALLAS, TX -- May 14th, 2026 -- Aemetis, Inc. (Nasdaq: AMTX): Stonegate Capital Partners updates coverage on Aemetis, Inc. (Nasdaq: AMTX). Aemetis’ 1Q26 further supports the transition from project buildout toward recurring low-carbon fuel monetization, with quarterly 45Z recognition and improving RNG economics beginning to appear in reported results. Revenue increased 27% y/y to $54.6M, gross profit improved to $2.8M from a $5.1M loss, and adj. EBITDA improved to negative $1.3M from negative $10.7M. The key change was recurring quarterly 45Z recognition tied to current-period production, with $4.0M recognized across Dairy RNG and California Ethanol following the full-year 2025 catch-up recognized in 4Q25. To view the full announcement, including downloadable images, bios, and more, click here. Key Takeaways: Credit monetization is moving from narrative to reported earnings. 1Q26 revenue rose 27% y/y to $54.6M, with gross profit turning positive and adj. EBITDA loss improving to $(1.3)M as 45Z recognition began contributing quarterly. Dairy RNG is becoming the clearest recurring cash flow proof point. RNG volumes increased 55% y/y to 110,000 MMBtu, while seven CARB pathways at a negative 380 CI score should materially improve LCFS capture as volumes scale. Keyes MVR remains the largest near-term EBITDA inflection catalyst. With construction advancing toward 2026 completion, MVR is expected to displace ~80% of fossil natural gas use and add ~$32M of annual cash flow. Click image above to view full announcement. About Stonegate Stonegate Capital Partners is a leading capital markets advisory firm providing investor relations, equity research, and institutional investor outreach services for public companies. Our affiliate, Stonegate Capital Markets (member FINRA) provides a full spectrum of investment banking, equity research and capital raising for public and private companies. Contacts: Stonegate Capital Partners (214) 987-4121 info@stonegateinc.com Source: Stonegate, Inc. Distributed by: Reportable, Inc.
May 14, 2026 08:00 ET NORTH LITTLE ROCK, Ark., May 14, 2026 -- First Orion, a leading provider of branded communication solutions, today announced a technology partnership with Glia, the leading platform for intelligent banking interactions, to deliver an identity-first approach to securing outbound customer communications. The integration combines First Orion's Call Authentication and spoof protection capabilities with Glia's Banking AI platform to help financial institutions protect brand identity, reduce fraud, and improve customer engagement across voice and digital channels. To view the full announcement, including downloadable images, bios, and more, click here. Key Takeaways: First Orion today announced a technology partnership with Glia, the leading platform for intelligent banking interactions, to deliver an identity-first approach to securing outbound customer communications. The integration combines First Orion's Call Authentication and spoof protection capabilities with Glia's Banking AI platform to help financial institutions protect brand identity, reduce fraud, and improve customer engagement across voice and digital channels. Unlike standalone authentication tools, the integration embeds identity verification directly into live customer interactions, helping reduce friction while strengthening trust at the point of engagement. Click image above to view full announcement. About Glia Glia is the No. 1 platform for intelligent banking interactions, providing an AI workforce purpose-built for the banking industry — and the only one with a zero-hallucination and prompt injection guarantee for customer and member AI. Trusted by over 700 financial institutions, Glia’s ChannelLess® architecture eliminates the friction of traditional support by unifying voice, digital and AI into a single efficient foundation. With 1,000+ pre-built banking goals and seamless human-to-AI handoffs, we help institutions slash operational costs and abandonment rates while accelerating growth in loans and deposits. Our mission is to help build thriving communities, ensuring that every banking interaction — AI or human — builds lasting trust and measurable value. Learn more at glia.com. About First Orion As a market leader in branded communication solutions, First Orion elevates the phone call and messaging experiences for businesses, carriers, and consumers. First Orion offers a comprehensive suite of branded communications solutions to improve customer engagement, enhance security and transparency, and provide actionable insights. In addition to branded calling and messaging, First Orion empowers businesses with advanced analytics to optimize call programs, real-time fraud detection to protect their customers, and other innovative solutions that enable enterprises to provide trust and transparency at scale. First Orion is a valued partner to Fortune 500 companies and is integrated into the largest U.S. mobile carriers. For more information, visit firstorion.com. Contacts: Katherine Waite katherine@triercompany.com Source: First Orion Distributed by: Reportable, Inc.
BOSTON, MA, MAY 14, 2026 Tevard Biosciences, Inc., a biotechnology company pioneering tRNA-based therapies to cure a broad range of genetic diseases, will share new preclinical data at the 2026 American Society of Gene & Cell Therapy (ASGCT) Annual Meeting, held from May 11-15 in Boston. Tevard will present data demonstrating that its next-generation suppressor tRNAs (sup-tRNAs) restore full‑length dystrophin protein and achieve wild-type levels of functional rescue in multiple mouse models of nonsense mutation-mediated Duchenne muscular dystrophy (DMD). The company will also present data showing that its novel sup-tRNAs provide durable rescue of full-length titin protein in a mouse model as well as functional rescue in human cardiomyocyte models of dilated cardiomyopathy caused by TTN truncations (DCM‑TTNtv). To view the full announcement, including downloadable images, bios, and more, click here. Key Takeaways: Tevard’s next‑generation suppressor tRNAs achieve ~100% restoration of full‑length dystrophin in DMD models and deliver durable full‑length titin rescue in TTN‑related cardiomyopathy. Tevard's compact tRNA architecture enables flexible AAV packaging, precise dose control, and broad applicability for pathogenic nonsense mutations across diverse unmet medical needs. The presented programs highlight the versatility of the suppressor tRNA platform and its ability to restore native protein expression in a cell-specific, durable manner. Click image above to view full announcement. About Tevard Biosciences Tevard Biosciences is pioneering tRNA‑based and other mRNA‑modulating therapies to cure a broad range of genetic diseases. The company’s suppressor tRNA platform is designed to restore endogenous, full‑length protein expression for diseases caused by premature termination codons. Tevard is advancing programs in muscular dystrophies, heart disease, and neurological disorders. For more information, visit www.tevard.com. Contacts: Michelle Linn Linnden Communications michelle@linndencom.com Source: Tevard Biosciences Distributed by: Reportable, Inc.
DALLAS, TX -- MAY 13, 2026 DALLAS, TX -- May 13, 2026 -- Valens Semiconductor Ltd.(NYSE:VLN): Stonegate Capital Partners Updates Coverage on Valens Semiconductor Ltd. (NYSE:VLN). Valens Semiconductor reported 1Q26 revenue of $16.9M, compared with $19.4M in 4Q25 and $16.8M in 1Q25. GAAP gross margin was 62.2%, above guidance of 57.0%–59.0%. Adjusted EBITDA loss was $(5.5)M, better than the guided range of $(7.9)M to $(7.5)M. While revenue stepped down sequentially following a stronger 4Q25, results were modestly ahead of expectations and management reiterated FY26 revenue guidance of $75.0M–$77.0M. We continue to view 2026 as a year of measured recovery and product-cycle execution, with near-term growth expected to build through the year as CIB returns to sequential growth, automotive remains steady, and A-PHY ecosystem development continues. Management noted that the broader supply-chain conditions remain an area to monitor; importantly, management also stated that it does not see risk to meeting its full-year targets. To view the full announcement, including downloadable images, bios, and more, click here. Key Takeaways: Execution remains ahead of plan despite a slower 1H setup. VLN delivered 1Q26 revenue of $16.9M, gross margin of 62.2% above guidance, and adjusted EBITDA loss of $(5.5)M, better than guided, while reiterating FY26 revenue guidance of $75.0M–$77.0M. 2H26 acceleration is the key thesis variable. Management expects a meaningfully stronger back half, driven by CIB sequential growth, ProAV momentum, and design wins/design-ins converting into customer launches in 3Q26 and 4Q26. Automotive and adjacent VA7000 markets support longer-duration optionality. Automotive revenue grew to $5.9M, while VA7000 traction in industrial machine vision and medical endoscopy expands the addressable opportunity beyond core A-PHY auto applications, though revenue contribution likely remains several quarters out. Click image above to view full announcement. About Stonegate Stonegate Capital Partners is a leading capital markets advisory firm providing investor relations, equity research, and institutional investor outreach services for public companies. Our affiliate, Stonegate Capital Markets (member FINRA) provides a full spectrum of investment banking services for public and private companies Contacts: Stonegate Capital Partners (214) 987-4121 info@stonegateinc.com Source: Stonegate, Inc. Distributed by: Reportable, Inc.
DALLAS, TX -- MAY 13, 2026 DALLAS, TX -- May 13, 2026 -- Surf Air Mobility Inc. (NYSE: SRFM): Stonegate Capital Partners Updates Coverage on Surf Air Mobility Inc. (NYSE: SRFM). SRFM’s 1Q26 results showed continued execution under the transformation plan, with revenue of $25.6M at the high end of guidance and up 9% y/y, while adjusted EBITDA loss of $12.3M outperformed guidance for a loss of $15.5M to $13.5M. Results were supported by improved On Demand private charter margins, cost controls across airline operations, and faster, more cost-efficient SurfOS development and deployment. To view the full announcement, including downloadable images, bios, and more, click here. Key Takeaways: Transformation plan is beginning to show operating leverage. 1Q26 revenue of $25.6M came in at the high end of guidance, while adjusted EBITDA loss of $(12.3)M beat guidance, supported by route rationalization, On Demand margin expansion, and tighter cost controls. On Demand and SurfOS are becoming the core growth/margin drivers. Surf On Demand revenue increased 77% y/y to $10.1M, with revenue per flight up 38% and gross margin up ~340 bps, while BrokerOS and OperatorOS traction suggest SurfOS is moving toward a commercial software platform. FY26 setup improved as guidance de-risked and valuation remains discounted. Management maintained FY26 revenue guidance of $128M–$138M and improved adjusted EBITDA loss guidance by ~40%, while SRFM trades at 1.3x FY27 EV/Revenue versus comps at 2.4x, supporting potential multiple re-rating if execution continues. Click image above to view full announcement. About Stonegate Stonegate Capital Partners is a leading capital markets advisory firm providing investor relations, equity research, and institutional investor outreach services for public companies. Our affiliate, Stonegate Capital Markets (member FINRA) provides a full spectrum of investment banking, equity research and capital raising for public and private companies. Contacts: Stonegate Capital Partners (214) 987-4121 info@stonegateinc.com Source: Stonegate, Inc. Distributed by: Reportable, Inc.
DALLAS, TX -- MAY 12, 2026 Dallas, TX -- May 12, 2026 -- MarketWise (NASDAQGM: MKTW): Stonegate Capital Partners Updates Coverage on MarketWise (NASDAQGM: MKTW). MKTW’s 1Q26 improved the forward setup by showing that the FY25 recovery is broadening into paid subscriber growth, higher ARPU, and reaffirmed FY26 cash flow targets. The reported GAAP revenue decline and negative CFFO understated underlying operating trends; revenue recognition continues to reflect older billings cohorts given the multi-year recognition structure of subscriptions, while CFFO reflected front-loaded marketing investment tied to improving customer acquisition conditions. In our view, the quarter supports the thesis that MarketWise has moved beyond the 2024 trough and is continuing to shift toward a smaller, higher-value subscriber base with improving monetization and meaningful capital return. To view the full announcement, including downloadable images, bios, and more, click here. Key Takeaways: Billings rose 15.5% y/y to $81.4M, signaling demand recovery ahead of GAAP revenue recognition. ARPU reached $738, up from $419 in 1Q25, reinforcing the shift toward higher-value subscribers. $52.7M cash, no debt, $1.80 dividend target, and $50M buyback support the shareholder-return thesis. Click image above to view full announcement. About Stonegate Stonegate Capital Partners is a leading capital markets advisory firm providing investor relations, equity research, and institutional investor outreach services for public companies. Our affiliate, Stonegate Capital Markets (member FINRA) provides a full spectrum of investment banking services for public and private companies. Contacts: Stonegate Capital Partners (214) 987-4121 info@stonegateinc.com Source: Stonegate, Inc. Distributed by: Reportable, Inc.
DALLAS, TX -- MAY 12, 2026 DALLAS, TX -- May 12, 2026 -- OS Therapies Inc. (NYSE: OSTX): Stonegate Capital Partners updates their coverage on OS Therapies Inc. (NYSE: OSTX). OS Therapies advanced materially through late-stage regulatory and commercialization preparation as OST-HER2 moved from Phase 2bsupported planning toward a more defined global approval pathway in recurrent, fully resected, pulmonary metastatic osteosarcoma. The key change is greater regulatory clarity: EMA initiated rolling review of the OSTHER2 Conditional Marketing Authorization dossier, while EMA and Australia’s TGA aligned on 3-year overall survival as the approvable efficacy endpoint. Management also positioned seroconversion biomarker data as supportive surrogate efficacy evidence, shifting the investment debate from early proof-of-concept toward execution across a dense 2026 catalyst calendar. Key milestones include 2.5-year OS data in mid-2Q26, FDA/MHRA meetings in 2Q26, Phase 3 initiation in Australia in 3Q26, 3-year OS data in early 4Q26, and a potential EMA CMA decision in 4Q26. To view the full announcement, including downloadable images, bios, and more, click here. Key Takeaways: Regulatory clarity is the core value inflection. EMA rolling review, TGA endpoint alignment, MHRA ATMP designation, and 2026 FDA/MHRA meetings shift OST-HER2 from Phase 2b validation toward an executable global approval pathway. Survival data remain the key catalyst stack. Mid-2Q26 2.5-year OS data and early-4Q26 3-year OS data should determine whether OSTX can complete EMA CMA submission and sustain accelerated-access momentum. Financing/PRV optionality bridges the regulatory window. The $5.25M raise plus expected $4.0M non-dilutive funding supports 2026 catalysts, while a potential PRV remains a meaningful approval-contingent valuation lever, with the latest public transaction at $205M. Click image above to view full announcement. About Stonegate Stonegate Capital Partners is a leading capital markets advisory firm providing investor relations, equity research, and institutional investor outreach services for public companies. Our affiliate, Stonegate Capital Markets (member FINRA) provides a full spectrum of investment banking services for public and private companies. Contacts: Stonegate Capital Partners (214) 987-4121 info@stonegateinc.com Source: Stonegate, Inc. Distributed by: Reportable, Inc.
DALLAS, TX -- MAY 8, 2026 DALLAS, TX -- May 8, 2026 -- Viemed Healthcare, Inc. (NASDAQ: VMD). Stonegate Capital Partners Updates Coverage on Viemed Healthcare, Inc. (NASDAQ: VMD). Viemed’s 1Q26 results showed improving growth quality, not just reported scale. Sleep, resupply, and maternal health are becoming larger contributors, reducing reliance on legacy ventilation and improving capital efficiency. At the same time, ventilation appears to be moving through the NCD transition, with better new-start activity and improving compliance, though turnover continues to pressure census. In our view, the broader mix is driving stronger FCF conversion as sleep, resupply, and maternal health scale. To view the full announcement, including downloadable images, bios, and more, click here. Key Takeaways: FCF conversion improved meaningfully. CFFO increased to $8.1M from $2.9M last year, while TTM FCF rose to $36.3M from $23.3M at YE25. Revenue mix continues to improve. Ventilator rentals declined to 46.9% of revenue from 54.4%, while Commercial payors increased to 23% from 17%. Sleep/resupply remain the clearest growth drivers. PAP patients increased 57% y/y to 35,938, new patient starts grew 42%, and resupply patients increased 47% y/y. Click image above to view full announcement. About Stonegate Stonegate Capital Partners is a leading capital markets advisory firm providing investor relations, equity research, and institutional investor outreach services for public companies. Our affiliate, Stonegate Capital Markets (member FINRA) provides a full spectrum of investment banking, equity research and capital raising for public and private companies. Contacts: Stonegate Capital Partners (214) 987-4121 info@stonegateinc.com Source: Stonegate, Inc. Distributed by: Reportable, Inc.
CHAPEL HILL, N.C. - MAY 11, 2026 iOrganBio, an innovator in intelligent cell manufacturing that is redefining how human cells are engineered and reliably produced at scale for research and therapeutic applications, including FDA-aligned New Approach Methodologies (NAMs), today announced the appointment of Jessica Owens to its Board of Directors. Jessica is a seasoned venture investor and serial founder with extensive experience building and scaling companies at the intersection of life sciences, health technology and AI. To view the full announcement, including downloadable images, bios, and more, click here. Key Takeaways: iOrganBio appoints Jessica Owens to its Board of Directors. Owens brings over 20 years of company-building and investing experience, including co-founding GRAIL, which raised over $1B and formed partnerships with Bristol Myers Squibb, Merck, and Johnson & Johnson, and serving as co-founder and General Partner at Initiate Ventures. iOrganBio says her counsel will be invaluable as it scales CellForge, expands partnerships, and advances AI-driven cell manufacturing to improve predictability and scalability from model development to cell therapies. Click image above to view full announcement. About iOrganBio iOrganBio is transforming human cell production with CellForge™, its AI-powered platform for consistent, scalable, and intelligent manufacturing of cells and organoids for in vitro modeling and cell therapies. By applying engineering precision to biology, CellForge uses AI and automation to guide cell development and make real-time adjustments aligned with defined biological profiles. At the core of the platform is iOrganBio’s functional human CellAtlas™, a comprehensive reference built from single-cell and multi-omics data that provides the digital blueprints for each cell type. This smart, closed-loop process delivers the accuracy, efficiency, and quality partners need to turn scientific ideas into breakthroughs, accelerating disease modeling, regenerative medicine, and drug development. iOrganBio is based at BioLabs in Chapel Hill, NC. For more information, visit iOrgan.Bio or follow us on LinkedIn. Contacts: Michelle Linn michelle@linndencom.com Source: iOrganBio Distributed by: Reportable, Inc.
EINDHOVEN (NETHERLANDS), MAY 11, 2026 Eindhoven (Netherlands), May 11, 2026 – eyeo today announced it has raised €40 million in Series A funding, bringing eyeo’s total funding to €55 million. The round is led by Innovation Industries, with participation from existing investors imec.xpand, Invest-NL Deep Tech Fund, QBIC fund, High-Tech Gründerfonds (HTGF) and Brabant Development Agency (BOM). To view the full announcement, including downloadable images, bios, and more, click here. Key Takeaways: Series A funds eyeo's drive to bring seven years of proven nanophotonic science to market as production-ready color-splitting sensors eyeo sensors capture three times more light for smartphones, XR devices, smart cities and more across a $30 billion imaging market Funding round is led by Innovation Industries, with participation from existing investors imec.xpand, Invest-NL Deep Tech Fund, QBIC fund, High-Tech Gründerfonds (HTGF) and Brabant Development Agency (BOM). Click image above to view full announcement. About eyeo eyeo is redefining imaging with the world’s most advanced nanophotonic color-splitting technology. For the first time, image sensors can capture all incoming light, overcoming the 70% light loss imposed by decades-old color filter technology. Instead of filtering photons, eyeo’s technology guides them directly to individual pixels, unlocking full light sensitivity and native color fidelity in any condition. Compatible with any CMOS sensor platform, eyeo enables sub-0.5-micron pixels for ultra-compact, high-performance imaging where image quality is critical. eyeo is headquartered at High Tech Campus Eindhoven (NL), with a sensor design center in Antwerp (BE). Contacts: Mike Sottak +1 650 248-9597 mike@wiredislandpr.com Guillaume Butin press@eyeo-imaging.com Source: eyeo.tech Distributed by: Reportable, Inc.
FOR IMMEDIATE RELEASE - MAY 8, 2026 UGI Utilities is scheduled to begin a system upgrades project in the City of Lancaster and Lancaster Township on Monday, May 11, 2026. The work is part of UGI’s commitment to provide safe and reliable service and is an opportunity for some homes and businesses along the project route to convert to natural gas. To view the full announcement, including downloadable images, bios, and more, click here. Click image above to view full announcement. UGI Utilities, Inc. is a natural gas and electric utility company that serves more than 760,000 customers. Additional information about UGI Utilities, Inc. is available at www.ugi.com. Contacts: John Mason (610) 334-7135 jmason@ugi.com Source: UGI Utilities Distributed by: Reportable, Inc.
DALLAS, TX -- MAY 8, 2026 DALLAS, TX -- May 8, 2026 -- NU Skin Enterprises Inc. (NYSE: NUS): Stonegate Capital Partners updates their coverage on NU Skin Enterprises Inc. (NYSE: NUS). NUS reported revenue, adj NI, and adj EPS of $320.6M, $6.8M, and $0.14, respectively. This compares to our estimates of $329.7M, $7.7M, and $0.15, respectively. Revenue came in near the low end of guidance, while adjusted EPS remained within range as management continued investing behind Prysm iO and emerging markets while maintaining cost discipline. Core Nu Skin gross margin improved 20 bps y/y to 76.9%, while adjusted operating margin was 3.6% versus 6.4% last year. The more important takeaway was management’s commentary that brand affiliate confidence improved and new sales leaders grew y/y exiting the quarter, suggesting early field stabilization as Prysm iO training and leader engagement scale. To view the full announcement, including downloadable images, bios, and more, click here. Key Takeaways: Prysm iO remains the core commercialization catalyst. Nearly 2M scans across 30,000+ devices supports early adoption, while 5% y/y subscription volume growth suggests the platform is beginning to improve customer engagement and recurring revenue quality. Field trends are showing early stabilization despite pressured headline KPIs. Sales leaders, paid affiliates, and customers declined 13%, 8%, and 14% y/y, respectively, but management cited improving brand affiliate confidence and y/y growth in new sales leaders exiting the quarter. Guidance implies confidence in a 2H26 improvement cadence. NUS maintained FY26 revenue and adjusted EPS guidance of $1.35B–$1.50B and $0.80–$1.20, supported by broader Prysm iO adoption, India’s planned year-end launch, and continued cost discipline. Click image above to view full announcement. About Stonegate Stonegate Capital Partners is a leading capital markets advisory firm providing investor relations, equity research, and institutional investor outreach services for public companies. Our affiliate, Stonegate Capital Markets (member FINRA) provides a full spectrum of investment banking services for public and private companies. Contacts: Stonegate Capital Partners (214) 987-4121 info@stonegateinc.com Source: Stonegate, Inc. Distributed by: Reportable, Inc.
FOR IMMEDIATE RELEASE - MAY 8, 2026 UGI Utilities is scheduled to begin a system upgrades project in Salem Township, Luzerne County on Monday, May 11, 2026. The work is part of UGI’s commitment to provide safe and reliable service and is an opportunity for some homes and businesses along the project route to convert to natural gas. To view the full announcement, including downloadable images, bios, and more, click here. Click image above to view full announcement. UGI Utilities, Inc. is a natural gas and electric utility company that serves more than 760,000 customers. Additional information about UGI Utilities, Inc. is available at www.ugi.com. Contacts: John Mason (610) 334-7135 jmason@ugi.com Source: UGI Utilities Distributed by: Reportable, Inc.
DALLAS, TX -- MAY 8, 2026 DALLAS, TX -- May 8th, 2026 -- OppFi, Inc. (NYSE: OPFI): Stonegate Capital Partners Updates Coverage on OppFi (NYSE: OPFI). OppFi’s 1Q26 results were steady, but the bigger development was its shift toward a bank-enabled, deposit-funded model through the pending BNCC acquisition. Revenue and receivables grew despite lower originations, as tighter credit, inflation, weaker sentiment, and higher average tax refunds temporarily reduced loan demand. Higher charge-offs pressured adjusted earnings, but expense discipline held as management invested across LOLA, Model 7, LOC, SMB lending, and BNC integration. In our view, OppFi is prioritizing credit discipline and long-term platform expansion over near-term volume growth. To view the full announcement, including downloadable images, bios, and more, click here. Key Takeaways: BNCC meaningfully expands the growth runway: The pending acquisition adds ~$1.0B of low-cost deposits, supports national expansion, and is expected to drive 25%+ adjusted EPS accretion in year one. Credit discipline supported a higher-quality revenue base: Net originations declined 7.0% y/y to $176.0M, but receivables grew 9.4% to $444.9M and revenue increased 8.3% to a record $151.9M. Product and technology investments add multiple 2026 catalysts: LOLA migration begins in May, Model 7 is expected in fall 2026, and LOC launches this summer, while FY26 guidance remains intact at $650M-$675M of revenue and $1.76-$1.84 of adjusted EPS. Click image above to view full announcement. About Stonegate Stonegate Capital Partners is a leading capital markets advisory firm providing investor relations, equity research, and institutional investor outreach services for public companies. Our affiliate, Stonegate Capital Markets (member FINRA) provides a full spectrum of investment banking, equity research and capital raising for public and private companies. Contacts: Stonegate Capital Partners (214) 987-4121 info@stonegateinc.com Source: Stonegate, Inc. Distributed by: Reportable, Inc.
BELLEVUE, WA, PALM BEACH, FL AND TORONTO, CA- MAY 8, 2026 Entrepreneurs Romi Mahajan, Paras Shah, and Megan Mitchell launch Mellifluous Fusion, an agency focused on PR, positioning, messaging, and narratives for the fusion energy ecosystem and other science-based industries. The company will initially focus on nuclear energy (fission, fusion, and hybrid scenarios) including adjacent areas like powering Data Centers and AI. To view the full announcement, including downloadable images, bios, and more, click here. Key Takeaways: Mellifluous Fusion launched by Fusion Entrepreneur, Marketing Executive, and Operations Leader The company will focus on positioning, messaging, content, and PR for the Fusion Energy and related industries Mellifluous Fusion welcomes the further growth of the Fusion Energy industry Click image above to view full announcement. About Mellifluous Fusion Nuclear fusion promises the world a source of abundant and clean baseload power. As the demands of technological societies increase and as new workloads like AI boom, Fusion is at the fore. Great strides have been made and still there is a distance to go, to make this breakthrough form of energy commercially viable at scale. Fusion is a convergence point between science, technology, economics, politics, innovation, and sociology. To get where the world needs us to get, we need to create the finest narratives, backed by science and engineering, and to stake fusion’s claim as fundamental to humanity’s future. Mellifluous Fusion is dedicated to drive that narrative through ideation, production, strategy, and collaboration. Welcome to Mellifluous Fusion. www.mellifluousfusion.ai Contacts: Romi Mahajan romi@thekkmgroup.com Source: Mellifluous Fusion Distributed by: Reportable, Inc.
DALLAS, TX -- MAY 7, 2026 DALLAS, TX -- May 7th, 2026 -- BlackSky Technology, Inc. (NYSE: BKSY): Stonegate Capital Partners Updates Coverage on BlackSky Technology, Inc. (NYSE: BKSY). BKSY’s 1Q26 marked a clearer Gen-3 commercialization inflection, with accelerating sovereign contract adoption, improving in-year revenue visibility, and management raising FY26 revenue and adj. EBITDA guidance. While reported revenue remained affected by Mission Solutions timing, the more important development was the continued scaling of higher-margin Gen-3 subscription services and the operational expansion of the constellation to four satellites, enabling daily revisit rates for 35cm imagery across key regions of interest worldwide. In our view, the quarter further supports BKSY’s positioning within commercial geospatial intelligence as recurring subscription mix, backlog conversion, and operating leverage continue improving. To view the full announcement, including downloadable images, bios, and more, click here. Key Takeaways: Gen-3 commercialization is accelerating. BKSY announced up to $160M of new wins, with early pilots converting into larger recurring subscription awards. FY26 visibility improved. Management raised revenue guidance to $130M-$150M and adj. EBITDA to $12M-$24M, while maintaining CapEx guidance. Constellation scale is improving the margin setup. Four Gen-3 satellites are now operational, supporting daily 35cm revisit capability, with at least eight expected on orbit by year-end. Click image above to view full announcement. About Stonegate Stonegate Capital Partners is a leading capital markets advisory firm providing investor relations, equity research, and institutional investor outreach services for public companies. Our affiliate, Stonegate Capital Markets (member FINRA) provides a full spectrum of investment banking services for public and private companies. Contacts: Stonegate Capital Partners (214) 987-4121 info@stonegateinc.com Source: Stonegate, Inc. Distributed by: Reportable, Inc.
DALLAS, TX -- MAY 7, 2026 DALLAS, TX -- May 7, 2026 -- Gladstone Commercial Corp. (NasdaqGS: GOOD): Stonegate Capital Partners Updates Coverage on Gladstone Commercial Corp. (NasdaqGS: GOOD). GOOD reported revenue, FFO per share, and AFFO per share of $41.9M, $0.35, and $0.30, respectively. This compares to our/consensus estimates of $43.5M/$42.9M, $0.36/$0.35, and $0.25/$0.26. The q/q decline appears largely tied to 4Q25 items, including a lease termination fee and easement settlement, rather than a material change in portfolio quality. While the quarter did not meaningfully change the growth outlook, recurring portfolio fundamentals remained stable, with continued focus on industrial mix shift, office rollover management, and dividend coverage. To view the full announcement, including downloadable images, bios, and more, click here. Key Takeaways: Recurring portfolio fundamentals remained steady. Leasing activity, rent collection, and tenant credit quality support GOOD’s stable operating profile despite modest q/q noise. Industrial repositioning continues to strengthen the portfolio. Industrial leasing, 2027 renewal visibility, and sale-leaseback opportunities support continued mix improvement. Dividend coverage remains supported by stable cash flows. FFO coverage, manageable maturities, and limited floating-rate exposure provide flexibility as GOOD advances its industrial acquisition strategy. Click image above to view full announcement. Stonegate Capital Partners is a leading capital markets advisory firm providing investor relations, equity research, and institutional investor outreach services for public companies. Our affiliate, Stonegate Capital Markets (member FINRA) provides a full spectrum of investment banking services for public and private companies. Contacts: Stonegate Capital Partners (214) 987-4121 info@stonegateinc.com Source: Stonegate, Inc. Distributed by: Reportable, Inc.
FOR IMMEDIATE RELEASE - MAY 7, 2026 UGI Utilities, Inc. is hosting commercial and industrial customers and power generation professionals to discuss how natural gas will fuel tomorrow’s energy needs. Powering the Future will be held Friday, May 15, 2026, at UGI’s Learning Center. To view the full announcement, including downloadable images, bios, and more, click here. Click image above to view full announcement. UGI Utilities, Inc. is a natural gas and electric utility company that serves more than 760,000 customers. Additional information about UGI Utilities, Inc. is available at www.ugi.com. Contacts: John Mason (610) 334-7135 jmason@ugi.com Source: UGI Utilities Distributed by: Reportable, Inc.
DALLAS, TEXAS - MAY 7, 2026 - MedCognetics, Inc., a company focusing on medical imaging AI, today and a member of the Amazon Web Services (AWS) Partner Network (APN), announced a collaboration with Health Within Reach Foundation (HWRF), a nonprofit striving to bring quality healthcare within reach for the underprivileged, to deploy AI-enabled mobile mammography units in India, bringing critical breast cancer screening services directly to underserved populations. To view the full announcement, including downloadable images, bios, and more, click here. Key Takeaways: We are combining accessible, inclusive, and affordable care to communities everywhere. Click image above to view full announcement. About MedCognetics, Inc. MedCognetics provides an advanced AI software platform that integrates into radiology workflow. In addition, the AI algorithm is trained on a diverse global patient dataset to mitigate data bias. The future of AI in healthcare is unbiased services and MedCognetics is at the forefront of creating a more predictable medical outcome and ultimately saving lives. Founded in 2020, the company is based in Dallas, Texas. For more information, please visit our website at www.medcognetics.com. Contacts: Alicia V. Nieva-Woodgate +1 720.808.0086 alicia@anwnetworks.com Source: MedCognetics, Inc. Distributed by: Reportable, Inc.
NEW YORK, NY MAY 7, 2026 The April 2026 Wellness Index Report has identified three top-rated U.S. wellness providers leading the nationwide Superhuman Protocol Challenge, signaling a shift away from seasonal weight-loss trends toward cellular-level health optimization. To view the full announcement, including downloadable images, bios, and more, click here. Key Takeaways: The April 2026 Wellness Index Report signals a shift from seasonal weight-loss trends to practitioner-led, multi-modality protocols that optimize cellular function for long-term health outcomes. Powered by Da Vinci Medical and promoted by Daymond John, the Superhuman Protocol Challenge invites participants to complete sessions at certified wellness centers for a chance to win an at-home system valued around $18,000, with entries closing June 30, 2026 and a winner announced July 1, 2026. The report names Physical Evidence Chiropractic, Boro Holistic Health, and April Berkowitz (Private Practice) as the top providers leading the Challenge, selected through the Biohacking Index’s expert-verified, multi-step evaluation process. Click image above to view full announcement. About the Wellness Index Report The Wellness Index Report is a practitioner-led evaluation platform that assesses wellness providers and technologies through a four-step process including expert nomination, customer feedback, clinical review, and ongoing rating analysis. It is designed to provide transparent, third-party validation in the rapidly growing wellness and biohacking industry. Contacts: Wellness Internal PR Team 914-846-9444 we@wellnesseternal.com Source: Wellness Internal Distributed by: Reportable, Inc.
Temecula, CA, May 5, 2026 Since first establishing operations in Temecula in 1989, MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, has grown its Temecula site into a center for advanced biomedical and biotechnical manufacturing. To view the full announcement, including downloadable images, bios, and more, click here. Key Takeaways: MilliporeSigma has been in Temecula since 1989 and has steadily expanded the site into a major center for biomedical manufacturing. The location isn’t just operational, it’s central to global work in antibody development, stem cell technologies, and tools used by researchers worldwide. Recent investments—like the HUB Organoids acquisition and a new organoid development lab, position Temecula at the forefront of cutting-edge research. The site is now playing a major role in advancing disease modeling, drug screening, and personalized medicine using patient-derived models. MilliporeSigma’s impact in Temecula goes beyond biotech. The company actively supports local education (STEM programs), nonprofits, and community initiatives like food drives—showing a long-term commitment to being part of the Temecula community, not just operating within it. Click image above to view full announcement. The Southern California Wine Country EDC is a nonprofit economic-development organization serving Temecula, Menifee, Lake Elsinore, Wildomar and southwestern Riverside County. For more than 30 years, the EDC has helped businesses relocate, expand or start up in one of Southern California’s fastest-growing and most strategic regions. Leveraging partnerships, incentives and a business-friendly environment, the EDC is committed to fostering sustainable growth, innovation and quality of life. SoCalWineCountryEDC.com Contacts: Liselle DeGrave, APR 951-764-0865 Liselle@DeGravePR.com Source: Southern California Wine Country EDC Distributed by: Reportable, Inc.
May 05, 2026 NORTH LITTLE ROCK, Ark., May 05, 2026 -- First Orion, a leading provider of branded communications solutions, today announced a partnership with Vodafone to bring network-based INFORM Branded Calling capabilities to enterprise customers across the United Kingdom, helping businesses clearly identify themselves and improve answer rates. To view the full announcement, including downloadable images, bios, and more, click here. Key Takeaways: First Orion today announced a partnership with Vodafone to bring network-based INFORM Branded Calling capabilities to enterprise customers across the United Kingdom, helping businesses clearly identify themselves and improve answer rates. The launch comes at a critical time for the UK market, where scam calls are a daily concern, and consumers are increasingly reluctant to answer unknown or unverified numbers, making it harder for legitimate businesses to reach customers. The UK launch utilizes Vodafone’s CAMARA-based network APIs to verify and brand calls enabling enterprises to present verified, recognizable identities at scale across Vodafone’s network. Click image above to view full announcement. About First Orion As a market leader in branded communication solutions, First Orion elevates the phone call and messaging experiences for businesses, carriers, and consumers. First Orion offers a comprehensive suite of branded communications solutions to improve customer engagement, enhance security and transparency, and provide actionable insights. In addition to branded calling and messaging, First Orion empowers businesses with advanced analytics to optimize call programs, real-time fraud detection to protect their customers, and other innovative solutions that enable enterprises to provide trust and transparency at scale. First Orion is a valued partner to Fortune 500 companies and is integrated into the largest U.S. mobile carriers. For more information, firstorion.com. Contacts: Katherine Waite 617 599 9798 katherine@triercompany.com Source: First Orion Distributed by: Reportable, Inc.
DALLAS, TX -- May 4, 2026 DALLAS, TX -- May 4th, 2026 -- Civeo Corporation (NYSE: CVEO): Stonegate Capital Partners Updates Coverage on Civeo Corporation (NYSE: CVEO). CVEO reported revenue and adj EBITDA of $172.7M and $22.5M, respectively. This compares to our/consensus estimates of $154.6M/$154.7M and $16.3M/$16.8M, respectively. Net loss improved to $3.8M from $9.8M in 1Q25, while operating cash flow was $(9.7)M, reflecting typical seasonal working capital use. Capex remained modest at $4.1M and was primarily maintenance-related. The key takeaway is not simply the revenue beat; rather, 1Q showed better Canadian margin conversion, continued Australian services contribution, and improving North American infrastructure visibility, partially offset by cost inflation and customer discipline that kept FY26 EBITDA guidance unchanged. To view the full announcement, including downloadable images, bios, and more, click here. Key Takeaways: FY26 EBITDA guidance stayed unchanged as diesel, labor inflation, and customer discipline limit near-term flow-through. 1Q26 upside was quality-driven, with Canada margin recovery and Australia services strength—not just revenue outperformance. Improving Canada execution and stable Australia demand underpin more durable earnings and clearer forward visibility. Click image above to view full announcement. About Stonegate Stonegate Capital Partners is a leading capital markets advisory firm providing investor relations, equity research, and institutional investor outreach services for public companies. Our affiliate, Stonegate Capital Markets (member FINRA) provides a full spectrum of investment banking, equity research and capital raising for public and private companies. Contacts: Stonegate Capital Partners (214) 987-4121 info@stonegateinc.com Source: Stonegate, Inc. Distributed by: Reportable, Inc.
DALLAS, TX -- mAY 4, 2026 DALLAS, TX -- May 4th 2026 -- Provident Financial Services, Inc. (NYSE: PFS): Stonegate Capital Partners Updates Coverage on Provident Financial Services, Inc. (NYSE: PFS). Provident Financial Services delivered a steady 1Q26, with the post-Lakeland profitability profile holding despite lower q/q EPS and a more visible credit watch item. Net income was $79.4M, or $0.61 diluted EPS, versus $83.4M, or $0.64, in 4Q25, while ROAA was 1.29%, Pre-provision net-revenue ROAA was 1.75%, and ROATCE was 16.58%. Revenue remained above $225M for the second consecutive quarter, as lower net interest income was offset by record noninterest income of $31.5M. In our view, the quarter supports the case that PFS can sustain a higher post-Lakeland profitability profile through core margin improvement, fee income contribution, and tangible book value growth, though the senior housing-related NPL increase is now the key item to monitor. To view the full announcement, including downloadable images, bios, and more, click here. Key Takeaways: Loan growth setup improved, as payoffs normalized and the commercial pipeline reached a record $3.11B. PFS’s post-Lakeland earnings power is holding, with core margin expansion and record fee income supporting profitability. Capital build remains a quiet positive, with TBV up 2.1% q/q and TCE improving to 8.55%. Click image above to view full announcement. About Stonegate Stonegate Capital Partners is a leading capital markets advisory firm providing investor relations, equity research, and institutional investor outreach services for public companies. Our affiliate, Stonegate Capital Markets (member FINRA) provides a full spectrum of investment banking, equity research and capital raising for public and private companies. Contacts: Stonegate Capital Partners (214) 987-4121 info@stonegateinc.com Source: Stonegate, Inc. Distributed by: Reportable, Inc.
April 30, 2026 -- New York, New York Tanooki Labs and ReportableNews have joined forces to launch a new tool that is set to revolutionize the press release industry. The tool is called ReportaBot, and it uses the latest technology to automatically generate press releases using ChatGPT. The launch of ReportaBot is a significant milestone for the B2B industry, and it will enable businesses to create high-quality press releases quickly and easily. To view the full announcement, including downloadable images, bios, and more, click here. Key Takeaways: ReportaBot is an innovative tool that uses ChatGPT AI technology to generate high-quality press releases automatically, which will save businesses time and money. ReportableNews and Tanooki Labs have come together to democratize corporate disclosure by putting communications teams in control and giving them tools to modernize disclosure and news intelligence. Reportable aims to change the dated corporate disclosure industry by launching ReportaBot, which is set to revolutionize the way businesses create press releases. Click image above to view full announcement. Tanooki Labs is a technology agency specializing in helping startup founders and established businesses bring their web and mobile applications to market and support growth. We are a team of smart, passionate product people focused on empowering entrepreneurs to get to their next milestone with development, product management and design all in one place. Reportable builds and offers business intelligences and communications tools for the digital age. Multiple products are integrated into a single software: Life Science Intelligence gives licensing, sales and marketing and communications teams a tool to track the latest business and scientific developments affecting their industry; A service-based media monitoring and PR metrics solution uses AI-based web crawling technology to track and measure communications campaigns; and the Company’s Newsrooms & releases offer companies a media-rich solution to manage communicate with external audience. Contacts: Victoria Ogino 6233634252 victoria@tanookilabs.com Source: Greendale Electronics Distributed by: Reportable, Inc.
DALLAS, TX -- mAY 1, 2026 DALLAS, TX -- May 1st 2026 -- NCS Multistage Holdings, Inc. (NASDAQ: NCSM): Stonegate Capital Partners Updates Coverage on NCS Multistage Holdings, Inc. (NASDAQ: NCSM). NCSM’s 1Q26 came in below expectations as Canada and select international projects weighed on results, while continued U.S. momentum helped offset the shortfall. In our view, the quarter does not change the core thesis around U.S. product momentum, ResMetrics integration, and the Company’s capital-light model, but it does highlight the timing risk embedded in Canada seasonality and project-based international work. The key change is cadence, with 2Q26 guidance implying a softer near-term trough and maintained FY26 Adjusted EBITDA guidance pointing to a more back-half-weighted recovery tied to deferred Canadian work, recurring Repeat Precision activity, and ResMetrics synergies. Separately, management noted that 2026 guidance excludes potential sliding sleeve deliveries for its first deepwater Gulf of Mexico opportunity, which could materialize in late 2026 or early 2027. To view the full announcement, including downloadable images, bios, and more, click here. Key Takeaways: 1Q26 missed on Canada/international timing, but U.S. revenue more than doubled, preserving the thesis. FY26 EBITDA guide was maintained, shifting focus to 2H recovery and Repeat Precision execution. Positive FCF and $53M liquidity support ResMetrics integration, capacity expansion, and growth investment. Click image above to view full announcement. About Stonegate Stonegate Capital Partners is a leading capital markets advisory firm providing investor relations, equity research, and institutional investor outreach services for public companies. Our affiliate, Stonegate Capital Markets (member FINRA) provides a full spectrum of investment banking, equity research and capital raising for public and private companies. Contacts: Stonegate Capital Partners (214) 987-4121 info@stonegateinc.com Source: Stonegate, Inc. Distributed by: Reportable, Inc.
SAN FRANCISCO, CA —APRIL 30, 2026 Superpanel, the intake infrastructure that manages high-volume legal intake from first contact through qualification and handoff, today announced that McCready Law, a 160 -person plaintiff personal injury firm, has deployed its platform, already driving 20% of the firm’s signed retainers. Built for organizations where every inbound inquiry represents a potential case, Superpanel enables McCready Law to convert more demand into signed cases, reduce lost opportunities at intake, and scale without adding headcount across offices. To view the full announcement, including downloadable images, bios, and more, click here. Key Takeaways: Superpanel enables McCready Law to convert more demand into signed cases, reduce lost opportunities at intake, and scale without adding headcount across offices. From first contact, McCready Law is able to convert more inbound inquiries into signed cases. McCready's model aligns closely with Superpanel's approach to scaling intake through consistent execution and outcome-driven workflows. Click image above to view full announcement. About Superpanel Superpanel is intake infrastructure designed to own high-volume intake operations in highly regulated environments. Built initially for plaintiff law firms, Superpanel manages intake end to end, from first contact through case qualification and handoff, with accountability for outcomes and human oversight where judgment is required. Founded in 2024, Superpanel has completed more than 250,000 intake workflows across personal injury, mass tort, employment, and lemon law. In the past year, organizations using Superpanel have signed more than 15,000 cases, collected, verified, and organized over 60,000 supporting documents, handled up to four times more inbound inquiries per intake staff member, and seen conversion rates increase by up to 300% within six months of full deployment, all without adding headcount. By owning intake execution end to end, Superpanel helps firms avoid the missed opportunities and intake inconsistency that can cost high-volume practices millions of dollars in lost cases each year. Learn more at www.superpanel.io. About McCready Law McCready Law is a plaintiff personal injury practice with offices throughout the Midwest and a people‑first, systems‑driven approach to representation. Under the leadership of Michael McCready, the firm has grown to approximately 160 professionals focused on personal injury advocacy, emphasizing sustainable growth, data‑informed decision‑making, and specialized operational disciplines that support both attorneys and support staff. Contacts: Elisabeth Rosario ellie@elisabethmrosario.com Source: Superpanel Distributed by: Reportable, Inc.